Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Hörst, Fabian; Rempe, Moritz; Heine, Lukas; Seibold, Constantin; Keyl, Julius; Baldini, Giulia; Ugurel, Selma; Siveke, Jens; Grünwald, Barbara; Egger, Jan; Kleesiek, Jens
    CellViT : Vision Transformers for precise cell segmentation and classification
    In: Medical Image Analysis Jg. 94 (2024) 103143
  • Weiss, L.; Fischer, L.E.; Heinemann, V.; Gieseler, F.; Hoehler, T.; Mayerle, J.; Quietzsch, D.; Reinacher-Schick, A.; Schenk, M.; Seipelt, G.; Siveke, Jens; Stahl, Michael; Kaiser, U.; Waldschmidt, D.T.; Dorman, K.; Zhang, D.; Westphalen, C.B.; Boeck, S.; Haas, M.
    Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy : a pooled analysis of five clinical trials from two decades of the German AIO study group
    In: ESMO Open Jg. 9 (2024) Nr. 4, 102944
  • Hartlapp, I.; Valta-Seufzer, D.; Siveke, Jens; Algül, H.; Goekkurt, E.; Siegler, G.; Martens, U.M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T.J.; Held, S.; Keller, R.; Anger, F.; Germer, C.T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V.
    Corrigendum to “Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: (NEOLAP-AIO-PAK-0113)” : results from a prospective, multicenter phase II trial
    In: ESMO Open Jg. 9 (2024) Nr. 5, 103463
  • Bauer, Nicolas; Balourdas, Dimitrios-Ilias; Schneider, Joel R.; Zhang, Xin; Berger, Lena M.; Berger, Benedict-Tilman; Schwalm, Martin P.; Klopp, Nick A.; Siveke, Jens; Knapp, Stefan; Joerger, Andreas C.
    Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization
    In: ACS Chemical Biology Jg. 19 (2024) Nr. 2, S. 266 - 279
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various Malignancies
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 3, S. 372 - 378
  • Hamacher, Rainer; Pabst, Kim M.; Cheung, Phyllis F.; Heilig, Christoph E.; Hüllein, Jennifer; Liffers, Sven-Thorsten; Borchert, Sabrina; Costa, Pedro Fragoso; Schaarschmidt, Benedikt; Kessler, Lukas; Miera, Monika A.; Droste, Margret; Akbulut, Merve; Falkenhorst, Johanna; Zarrad, Fadi; Kostbade, Karina; Mavroeidi, Ilektra A.; Glimm, Hanno; Umutlu, Lale; Schuler, Martin; Hübschmann, Daniel; Bauer, Sebastian; Fröhling, Stefan; Herrmann, Ken; Siveke, Jens; Schildhaus, Hans-Ulrich; Fendler, Wolfgang
    Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 2, S. 252 - 257
  • Godfrey, Laura K.; Forster, Jan; Liffers, Sven-Thorsten; Schröder, Christopher; Köster, Johannes; Henschel, Leonie; Ludwig, Kerstin U.; Lähnemann, David; Trajkovic-Arsic, Marija; Behrens, Diana; Scarpa, Aldo; Lawlor, Rita T.; Witzke, Kathrin E.; Sitek, Barbara; Johnsen, Steven A.; Rahmann, Sven; Horsthemke, Bernhard; Zeschnigk, Michael; Siveke, Jens
    Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation
    In: Clinical Epigenetics Jg. 16 (2024) Nr. 1, 13
  • Keyl, Julius; Bucher, A.; Jungmann, F.; Hosch, R.; Ziller, A.; Armbruster, R.; Malkomes, P.; Reissig, T.M.; Koitka, S.; Tzianopoulos, I.; Keyl, P.; Kostbade, K.; Albers, David; Markus, P.; Treckmann, Jürgen-Walter; Naßenstein, Kai; Haubold, Johannes; Makowski, M.; Forsting, Michael; Baba, Hideo Andreas; Kasper, Stefan; Siveke, Jens T.; Nensa, Felix; Schuler, Martin; Kaissis, G.; Kleesiek, Jens; Braren, R.
    Prognostic value of deep learning-derived body composition in advanced pancreatic cancer : A retrospective multicenter study
    In: ESMO Open Jg. 9 (2024) Nr. 1, 102219
  • Tuz, Ali A.; Ghosh, Susmita; Karsch, Laura; Ttoouli, Dimitris; Sata, Sai P.; Ulusoy, Özgür; Kraus, Andreas; Hoerenbaum, Nils; Wolf, Jan-Niklas; Lohmann, Sabrina; Zwirnlein, Franziska; Kaygusuz, Viola; Lakovic, Vivian; Tummes, Hannah-Lea; Beer, Alexander; Gallert, Markus; Thiebes, Stephanie; Qefalia, Altea; Cibir, Zülal; Antler, Medina; Korste, Sebastian; Haj Yehia, Elias; Michel, Lars; Rassaf, Tienush; Kaltwasser, Britta; Abdelrahman, Hossam; Mohamud Yusuf, Ayan; Wang, Chen; Yin, Dongpei; Haeusler, Lars; Lueong, Smiths; Richter, Mathis; Engel, Daniel; Stenzel, Martin; Soehnlein, Oliver; Frank, Benedikt; Solo-Nomenjanahary, Mialitiana; Ho-Tin-Noé, Benoît; Siveke, Jens; Totzeck, Matthias; Hoffmann, Daniel; Grüneboom, Anika; Hagemann, Nina; Hasenberg, Anja; Desilles, Jean-Philippe; Mazighi, Mikael; Sickmann, Albert; Chen, Jianxu; Hermann, Dirk M.; Gunzer, Matthias; Singh, Vikramjeet
    Stroke and myocardial infarction induce neutrophil extracellular trap release disrupting lymphoid organ structure and immunoglobulin secretion
    In: Nature Cardiovascular Research (2024) in press
  • Kessler, Lukas; Hirmas, Nader; Pabst, Kim M.; Hamacher, Rainer; Ferdinandus, Justin; Schaarschmidt, Benedikt M.; Milosevic, Aleksandar; Nader, Michael; Umutlu, Lale; Uhl, Waldemar; Reinacher-Schick, Anke; Lugnier, Celine; Witte, David; Niedergethmann, Marco; Herrmann, Ken; Fendler, Wolfgang P.; Siveke, Jens T.
    68Ga-Labeled Fibroblast Activation Protein Inhibitor (⁶⁸Ga-FAPI) PET for Pancreatic Adenocarcinoma : Data from the ⁶⁸Ga-FAPI PET Observational Trial
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 12, S. 1910 - 1917
  • Virchow, Isabel; Treckmann, Jürgen-Walter; Prasnikar, Nicole; Linden, Gabriele; Markus, Peter; Schumacher, Brigitte; Albers, David; Herold, Thomas; Ting, Saskia; Schmidt, Hartmut; Radunz, Sonja; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. 3, S. 89 - 99
  • Kebir, Sied; Ullrich, Vivien; Berger, Pia; Dobersalske, Celia; Langer, Sarah; Rauschenbach, Laurèl; Trageser, Daniel; Till, Andreas; Lorbeer, Franziska K.; Wieland, Anja; Wilhelm-Buchstab, Timo; Ahmad, Ashar; Fröhlich, Holger; Cima, Igor; Prasad, Shruthi; Matschke, Johann; Jendrossek, Verena; Remke, Marc; Grüner, Barbara M.; Rösch, Alexander; Siveke, Jens; Herold-Mende, Christel; Blau, Tobias; Keyvani, Kathy; van Landeghem, Frank K H; Pietsch, Torsten; Felsberg, Jörg; Reifenberger, Guido; Weller, Michael; Sure, Ulrich; Brüstle, Oliver; Simon, Matthias; Glas, Martin; Scheffler, Björn
    A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
    In: Clinical Cancer Research Jg. 29 (2023) Nr. 2, S. 488 - 500
  • Maßmann, M.; Treckmann, Jürgen Walter; Markus, P.; Schumacher, B.; Albers, D.; Ting, Saskia; Mende, B.; Roehrle, J.; Virchow, I.; Rosery, V.; Laue, K.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Schmid, Kurt Werner; Baba, Hideo Andreas; Siveke, Jens; Paul, A.; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Kasper, Stefan
    A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 5085 - 5094
  • Ko, Andrew H; Kim, Kyu-Pyo; Siveke, Jens; Lopez, Charles D; Lacy, Jill; O'Reilly, Eileen M; Macarulla, Teresa; Manji, Gulam A; Lee, Jeeyun; Ajani, Jaffer; Alsina Maqueda, Maria; Rha, Sun-Young; Lau, Janet; Al-Sakaff, Nedal; Allen, Simon; Lu, Danny; Shemesh, Colby S; Gan, Xinxin; Cha, Edward; Oh, Do-Youn
    Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer : MORPHEUS Phase Ib/II Umbrella Randomized Study Platform
    In: The Oncologist Jg. 28 (2023) Nr. 6, S. 553 - e472
  • Roehrle, Julius; Kasper, Stefan; Treckmann, Jürgen-Walter; Markus, Peter; Schumacher, Brigitte; Albers, David; Wendling, Johanna; Ting, Saskia; Mende, Bastian; Maßmann, Marlene; Markus, Maximilian; Virchow, Isabel; Rosery, Vivian; Laue, Katharina; Zaun, Gregor; Kostbade, Karina; Pogorzelski, Michael; Reissig, Timm M.; Liffers, Sven-Thorsten; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Schuler, Martin; Siveke, Jens; Wiesweg, Marcel
    Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. 4, S. 140 - 150
  • Cameron, Donald P.; Grosser, Jan; Ladigan, Swetlana; Kuzin, Vladislav; Iliopoulou, Evanthia; Wiegard, Anika; Benredjem, Hajar; Jackson, Kathryn; Liffers, Sven T.; Lueong, Smiths; Cheung, Phyllis F.; Vangala, Deepak; Pohl, Michael; Viebahn, Richard; Teschendorf, Christian; Wolters, Heiner; Usta, Selami; Geng, Keyi; Kutter, Claudia; Arsenian-Henriksson, Marie; Siveke, Jens; Tannapfel, Andrea; Schmiegel, Wolff; Hahn, Stephan A.; Baranello, Laura
    Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription
    In: Science Advances Jg. 9 (2023) Nr. 41, eadg5109
  • Patnana, Pradeep Kumar; Liu, Longlong; Frank, Daria; Nimmagadda, Subbaiah Chary; Behrens, Matthias; Ahmed, Helal; Xie, Xiaoqing; Liebmann, Marie; Wei, Lanying; Gerdemann, Andrea; Thivakaran, Aniththa; Humpf, Hans-Ulrich; Klotz, Luisa; Dugas, Martin; Varghese, Julian; Trajkovic-Arsic, Marija; Siveke, Jens; Hanenberg, Helmut; Opalka, Bertram; Dührsen, Ulrich; Reinhardt, Christian; Guenther, Ulrich; von Bubnoff, Nikolas; Khandanpour, Cyrus
    Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cells
    In: British Journal of Haematology Jg. 202 (2023) Nr. 5, S. 1033 - 1048
  • Hamacher, Rainer; Lanzafame, Helena; Mavroeidi, Ilektra A.; Pabst, Kim M.; Kessler, Lukas; Cheung, Phyllis F.; Bauer, Sebastian; Herrmann, Ken; Schildhaus, Hans-Ulrich; Siveke, Jens; Fendler, Wolfgang
    Fibroblast Activation Protein Inhibitor Theranostics : The Case for Use in Sarcoma
    In: PET Clinics Jg. 18 (2023) Nr. 3, S. 361 - 367
  • Dorst, Daphne N.; Smeets, Esther M M; Klein, Christian; Frielink, Cathelijne; Geijs, Daan; Trajkovic-Arsic, Marija; Cheung, Phyllis F Y; Stommel, Martijn W J; Gotthardt, Martin; Siveke, Jens T.; Aarntzen, Erik H J G; van Lith, Sanne A M
    Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma
    In: Molecular Pharmaceutics Jg. 20 (2023) Nr. 8, S. 4319 - 4330
  • Smeets, Esther M. M.; Dorst, Daphne N.; Franssen, Gerben M.; van Essen, Merijn S.; Frielink, Cathelijne; Stommel, Martijn W. J.; Trajkovic-Arsic, Marija; Cheung, Phyllis F.; Siveke, Jens; Wilson, Ian; Mascioni, Alessandro; Aarntzen, Erik H. J. G.; van Lith, Sanne A. M.
    Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy
    In: Cells Jg. 12 (2023) Nr. 10, 1420
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lückerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 711 - 716
  • Hörst, Fabian; Ting, Saskia; Liffers, Sven-Thorsten; Pomykala, Kelsey L.; Steiger, Katja; Albertsmeier, Markus; Angele, Martin K.; Lorenzen, Sylvie; Quante, Michael; Weichert, Wilko; Egger, Jan; Siveke, Jens; Kleesiek, Jens
    Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning
    In: JCO Clinical Cancer Informatics (JCO CCI) Jg. 7 (2023) S. e2300038
  • Rosery, Vivian; Mika, Stephan; Schmid, Kurt Werner; Reis, Henning; Stuschke, Martin; Treckmann, Jürgen; Markus, Peter; Schumacher, Brigitte; Albers, David; Mende, Bastian; Lahner, Harald; Wiesweg, Marcel; Schuler, Martin; Siveke, Jens; Kasper, Stefan
    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 4315 - 4325
  • Wang, Xin; Kutschat, Ana P.; Aggrey-Fynn, Joana; Hamdan, Feda H.; Graham, Rondell P.; Wixom, Alexander Q.; Souto, Yara; Ladigan-Badura, Swetlana; Yonkus, Jennifer A.; Abdelrahman, Amro M.; Alva-Ruiz, Roberto; Gaedcke, Jochen; Ströbel, Philipp; Kosinsky, Robyn Laura; Wegwitz, Florian; Hermann, Patrick; Truty, Mark J.; Siveke, Jens; Hahn, Stephan A.; Hessmann, Elisabeth; Johnsen, Steven A.; Najafova, Zeynab
    Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma
    In: Molecular Cancer Research Jg. 21 (2023) Nr. 9, S. 881 - 891
  • Dorman, Klara; Boeck, Stefan; Snijder, Robert J.; Siveke, Jens; Schenk, Michael; Mayerle, Julia; Caca, Karel; Freiberg-Richter, Jens; Fischer von Weikersthal, Ludwig; Kullmann, Frank; Reinacher-Schick, Anke; Fuchs, Martin; Kanzler, Stephan; Kunzmann, Volker; Ettrich, Thomas J.; Zhang, Danmei; Held, Swantje; Abdul-Ahad, Ayad; von Bergwelt-Baildon, Michael; Heinemann, Volker; Haas, Michael
    Integrated Analysis of the RASH Study with the Use of the “Burden of Therapy” (BOTh®TM) Methodology : A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer
    In: Current Oncology Jg. 30 (2023) Nr. 6, S. 5828 - 5834
  • Hamdan, Feda H.; Abdelrahman, Amro M.; Kutschat, Ana Patricia; Wang, Xin; Ekstrom, Thomas L.; Jalan-Sakrikar, Nidhi; Wegner Wippel, Catherine; Taheri, Negar; Tamon, Liezel; Kopp, Waltraut; Aggrey-Fynn, Joana; Bhagwate, Aditya V.; Alva-Ruiz, Roberto; Lynch, Isaac; Yonkus, Jennifer; Kosinsky, Robyn Laura; Gaedcke, Jochen; Hahn, Stephan A.; Siveke, Jens; Graham, Rondell; Najafova, Zeynab; Hessmann, Elisabeth; Truty, Mark J.; Johnsen, Steven A.
    Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer
    In: Gut Jg. 72 (2023) Nr. 6, S. 1174 - 1185
  • Erice, Oihane; Narayanan, Shruthi; Feliu, Iker; Entrialgo-Cadierno, Rodrigo; Malinova, Antonia; Vicentini, Caterina; Guruceaga, Elizabeth; Delfino, Pietro; Trajkovic-Arsic, Marija; Moreno, Haritz; Valencia, Karmele; Blanco, Ester; Macaya, Irati; Öhlund, Daniel; Khatri, Purvesh; Lecanda, Fernando; Scarpa, Aldo; Siveke, Jens T.; Corbo, Vincenzo; Ponz-Sarvise, Mariano; Vicent, Silve
    LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
    In: Clinical Cancer Research Jg. 29 (2023) Nr. 6, S. 1137 - 1154
  • Tintelnot, Joseph; Xu, Yang; Lesker, Till R.; Schönlein, Martin; Konczalla, Leonie; Giannou, Anastasios D.; Pelczar, Penelope; Kylies, Dominik; Puelles, Victor G.; Bielecka, Agata A.; Peschka, Manuela; Cortesi, Filippo; Riecken, Kristoffer; Jung, Maximilian; Amend, Lena; Bröring, Tobias S.; Trajkovic-Arsic, Marija; Siveke, Jens T.; Renné, Thomas; Zhang, Danmei; Boeck, Stefan; Strowig, Till; Uzunoglu, Faik G.; Güngör, Cenap; Stein, Alexander; Izbicki, Jakob R.; Bokemeyer, Carsten; Sinn, Marianne; Kimmelman, Alec C.; Huber, Samuel; Gagliani, Nicola
    Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer
    In: Nature Jg. 615 (2023) Nr. 7950, S. 168 - 174
  • Liffers, Sven-Thorsten; Godfrey, Laura; Frohn, Lisa; Haeberle, Lena; Yavas, Aslihan; Vesce, Rita; Goering, Wolfgang; Opitz, Friederike V.; Stoecklein, Nickolas; Knoefel, Wolfram Trudo; Schlitter, Anna Melissa; Klöppel, Guenter; Espinet, Elisa; Trumpp, Andreas; Siveke, Jens T.; Esposito, Irene
    Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
    In: Gut Jg. 72 (2023) Nr. 3, S. 522 - 534
  • Demmert, Tristan T.; Maric, Ines; Pomykala, Kelsey L.; Lueckerath, Katharina; Siveke, Jens; Schaarschmidt, Benedikt M.; Hamacher, Rainer; Herrmann, Ken; Fendler, Wolfgang P.
    Novel ⁶⁸Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine-Related Pitfalls
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 3, S. 368 - 371
  • Demmert, Tristan T.; Pomykala, Kelsey L.; Lanzafame, Helena; Pabst, Kim M.; Lueckerath, Katharina; Siveke, Jens; Umutlu, Lale; Hautzel, Hubertus; Hamacher, Rainer; Herrmann, Ken; Fendler, Wolfgang P.
    Oncologic Staging with ⁶⁸Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than ¹⁸F-FDG PET/CT
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 12, S. 1906 - 1909
  • Hassel, Jessica C.; Berking, Carola; Forschner, Andrea; Gebhardt, Christoffer; Heinzerling, Lucie; Meier, Friedegund; Ochsenreither, Sebastian; Siveke, Jens; Hauschild, Axel; Schadendorf, Dirk
    Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp
    In: European Journal of Cancer (EJC) Jg. 191 (2023) 112986
  • Lazaridis, Lazaros; Schmidt, Teresa; Oster, Christoph; Blau, Tobias; Pierscianek, Daniela; Siveke, Jens T.; Bauer, Sebastian; Schildhaus, Hans-Ulrich; Sure, Ulrich; Keyvani, Kathy; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin
    Precision neuro-oncology : A pilot analysis of personalized treatment in recurrent glioma
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 7, S. 3513 - 3526
  • Hohmann, Nicolas; Sprick, Martin Ronald; Pohl, Moritz; Ahmed, Azaz; Burhenne, Jürgen; Kirchner, Marietta; Le Cornet, Lucian; Kratzmann, Markus; Hajda, Jacek; Stenzinger, Albrecht; Steindorf, Karen; Delorme, Stefan; Schlemmer, Heinz-Peter; Riethdorf, Sabine; van Schaik, Ron; Pantel, Klaus; Siveke, Jens; Seufferlein, Thomas; Jäger, Dirk; Haefeli, Walter E.; Trumpp, Andreas; Springfeld, Christoph
    Protocol of the IntenSify-Trial : An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy
    In: Clinical and Translational Science (CTS) Jg. 16 (2023) Nr. 12, S. 2483 - 2493
  • Njouendou, Abdel Jelil; Szarvas, Tibor; Tiofack, Arnol Auvaker Zebaze; Kenfack, Rovaldo Nguims; Tonouo, Pamela Derliche; Ananga, Sidonie Noa; Bell, Esther H M Dina; Simo, Gustave; Hoheisel, Jörg D; Siveke, Jens; Lueong, Smiths S.
    SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis
    In: Molecular Cancer Jg. 22 (2023) Nr. 1, 52
  • Reissig, T.M.; Tzianopoulos, I.; Liffers, S.-T.; Rosery, V.K.; Guyot, M.; Ting, S.; Wiesweg, Marcel; Kasper, S.; Meister, P.; Herold, T.; Schmidt, H.H.; Schumacher, B.; Albers, David; Markus, P.; Treckmann, J.; Schuler, Martin; Schildhaus, Hans-Ulrich; Siveke, Jens
    Smaller panel, similar results : Genomic profiling and molecularly informed therapy in pancreatic cancer
    In: ESMO Open Jg. 8 (2023) Nr. 3, 101539
  • Pabst, Kim M.; Trajkovic-Arsic, Marija; Cheung, Phyllis F Y; Ballke, Simone; Steiger, Katja; Bartel, Timo; Schaarschmidt, Benedikt M.; Milosevic, Aleksandar; Seifert, Robert; Nader, Michael; Kessler, Lukas; Siveke, Jens; Lückerath, Katharina; Kasper, Stefan; Herrmann, Ken; Hirmas, Nader; Schmidt, Hartmut; Hamacher, Rainer; Fendler, Wolfgang
    Superior Tumor Detection for ⁶⁸Ga-FAPI-46 Versus ¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1049 - 1055
  • Tomsitz, Dirk; Ruf, Theresa; Heppt, Markus; Staeger, Ramon; Ramelyte, Egle; Dummer, Reinhard; Garzarolli, Marlene; Meier, Friedegund; Meier, Eileen; Richly, Heike; Gromke, Tanja; Siveke, Jens T.; Franklin, Cindy; Klespe, Kai-Christian; Mauch, Cornelia; Kilian, Teresa; Seegräber, Marlene; Schilling, Bastian; French, Lars E.; Berking, Carola; Heinzerling, Lucie
    Tebentafusp in Patients with Metastatic Uveal Melanoma : A Real-Life Retrospective Multicenter Study
    In: Cancers Jg. 15 (2023) Nr. 13, 3430
  • Weiss, Lena; Heinemann, Volker; Fischer, Laura E.; Gieseler, Frank; Hoehler, Thomas; Mayerle, Julia; Quietzsch, Detlef; Reinacher-Schick, Anke; Schenk, Michael; Seipelt, Gernot; Siveke, Jens; Stahl, Michael; Vehling-Kaiser, Ursula; Waldschmidt, Dirk T.; Dorman, Klara; Zhang, Danmei; Westphalen, C. Benedikt; von Bergwelt-Baildon, Michael; Boeck, Stefan; Haas, Michael
    Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer : Is it really a valid tool for patient selection?
    In: Clinical and Translational Oncology (2023) in press
  • Hoffmeister‐Wittmann, Paula; Mock, Andreas; Nichetti, Federico; Korell, Felix; Heilig, Christop E.; Scherr, Anna‐Lena; Günther, Michael; Albrecht, Thomas; Kelmendi, Eblina; Xu, Kaiyu; Nader, Luisa; Kessler, Annika; Schmitt, Nathalie; Fritzsche, Sarah; Weiler, Sofia; Sobol, Benjamin; Stenzinger, Albrecht; Boeck, Stefan; Westphalen, Christoph B.; Schulze‐Osthoff, Klaus; Trojan, Jörg; Kindler, Thomas; Weichert, Wilko; Spiekermann, Karsten; Bitzer, Michael; Folprecht, Gunnar; Illert, Anna‐Lena; Boerries, Melanie; Klauschen, Frederick; Ochsenreiter, Sebastian; Siveke, Jens; Bauer, Sebastian; Glimm, Hanno; Brors, Benedikt; Hüllein, Jennifer; Hübschmann, Daniel; Uhrig, Sebastian; Horak, Peter; Kreutzfeld, Simon; Banales, Jesus M.; Springfeld, Christoph; Jäger, Dirk; Schirmacher, Peter; Roessler, Stephanie; Ormanns, Steffen; Goeppert, Benjamin; Fröhling, Stefan; Köhler, Bruno C.
    Bcl-x(L) as prognostic marker and potential therapeutic target in cholangiocarcinoma
    In: Liver International Jg. 42 (2022) Nr. 12, S. 2855 - 2870
  • Albrecht, Lea Jessica; Höwner, Anna; Griewank, Klaus; Lueong, Smiths S.; von Neuhoff, Nils; Horn, Peter; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, Susanne; Siveke, Jens; Schadendorf, Dirk; Váraljai, Renáta; Rösch, Alexander
    Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
    In: Clinical and Translational Medicine Jg. 12 (2022) Nr. 11, e1090
  • Metzenmacher, Martin; Hegedüs, Balazs; Forster, Jan; Schramm, Alexander; Horn, Peter; Klein, Christoph A.; Bielefeld, Nicola; Ploenes, Till; Aigner, Clemens; Theegarten, Dirk; Schildhaus, Hans-Ulrich; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer
    In: Translational Oncology Jg. 15 (2022) Nr. 1, 101279
  • Jahn, A.; Rump, A.; Widmann, T.J.; Heining, C.; Horak, P.; Hutter, B.; Paramasivam, N.; Uhrig, S.; Gieldon, L.; Drukewitz, S.; Kübler, A.; Bermudez, M.; Hackmann, K.; Porrmann, J.; Wagner, J.; Arlt, M.; Franke, M.; Fischer, J.; Kowalzyk, Z.; William, D.; Weth, V.; Oster, S.; Fröhlich, M.; Hüllein, J.; Valle González, C.; Kreutzfeldt, S.; Mock, A.; Heilig, C.E.; Lipka, D.B.; Möhrmann, L.; Hanf, D.; Oleś, M.; Teleanu, V.; Allgäuer, M.; Ruhnke, L.; Kutz, O.; Knurr, A.; Laßmann, A.; Endris, V.; Neumann, O.; Penzel, R.; Beck, K.; Richter, D.; Winter, U.; Wolf, S.; Pfütze, K.; Geörg, C.; Meißburger, B.; Buchhalter, I.; Augustin, M.; Aulitzky, W.E.; Hohenberger, P.; Kroiss, M.; Schirmacher, P.; Schlenk, R.F.; Keilholz, U.; Klauschen, F.; Folprecht, G.; Bauer, Sebastian; Siveke, Jens; Brandts, C.H.; Kindler, T.; Boerries, M.; Illert, A.L.; von Bubnoff, N.; Jost, P.J.; Metzeler, K.H.; Bitzer, M.; Schulze-Osthoff, K.; von Kalle, C.; Brors, B.; Stenzinger, A.; Weichert, W.; Hübschmann, D.; Fröhling, S.; Glimm, H.; Schröck, E.; Klink, B.
    Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
    In: Annals of Oncology Jg. 33 (2022) Nr. 11, S. 1186 - 1199
  • Pijnappel, Esther N.; Suurmeijer, J. Annelie; Groot Koerkamp, Bas; Kos, Milan; Siveke, Jens; Salvia, Roberto; Ghaneh, Paula; van Eijck, Casper H. J.; van Etten-Jamaludin, Faridi S.; Abrams, Ross; Brasiūnienė, Birute; Büchler, Markus W.; Casadei, Riccardo; van Laethem, Jean-Luc; Berlin, Jordan; Boku, Narikazu; Conroy, Thierry; Golcher, Henriette; Sinn, Marianne; Neoptolemos, John P.; van Tienhoven, Geertjan; Besselink, Marc G.; Wilmink, Johanna W.; van Laarhoven, Hanneke W. M.
    Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients with Resectable or Borderline Resectable Disease (COMM-PACT-RB) : A Systematic Review and Delphi Consensus Statement
    In: JAMA Oncology Jg. 8 (2022) Nr. 6, S. 929 - 937
  • Westphalen, C. Benedikt; Bokemeyer, Carsten; Büttner, Reinhard; Fröhling, Stefan; Gaidzik, Verena I.; Glimm, Hanno; Hacker, Ulrich T.; Heinemann, Volker; Illert, Anna L.; Keilholz, Ulrich; Kindler, Thomas; Kirschner, Martin; Schilling, Bastian; Siveke, Jens; Schroeder, Thomas; Tischler, Verena; Wagner, Sebastian; Weichert, Wilko; Zips, Daniel; Loges, Sonja; Schadendorf, Dirk; Schildhaus, Hans-Ulrich; Working Group Molecular Diagnostics and Therapy
    Corrigendum to “Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group Molecular Diagnostics and Therapy”
    In: European Journal of Cancer (EJC) Jg. 162 (2022) S. 245 - 246
  • Striefler, Jana K.; Reissig, Timm M.; Kunzmann, Volker; Westphalen, C. Benedikt; Böck, Stefan; Ettrich, Thomas J.; Lutz, Manfred P.; Waldschmidt, Dirk T.; Brunner, Thomas; Uhl, Waldemar; Sinn, Marianne; Siveke, Jens
    Das Pankreaskarzinom : Klinische Projekte der onkologischen Studiengruppen in Deutschland (ACO, AIO und ARO)
    In: Der Onkologe Jg. 28 (2022) Nr. Suppl. 1, S. 30 - 35
  • Heid, Irina; Trajkovic-Arsic, Marija; Lohöfer, Fabian; Kaissis, Georgios; Harder, Felix N; Mayer, Moritz; Topping, Geoffrey J; Jungmann, Friderike; Crone, Barbara; Wildgruber, Moritz; Karst, Uwe; Liotta, Lucia; Algül, Hana; Yen, Hsi-Yu; Steiger, Katja; Weichert, Wilko; Siveke, Jens; Makowski, Marcus R; Braren, Rickmer F
    Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization.
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2022) Nr. 1, S. 115 - 129
  • Heid, Irina; Münch, Corinna; Karakaya, Sinan; Lueong, Smiths S.; Winkelkotte, Alina M.; Liffers, Sven T.; Godfrey, Laura; Cheung, Phyllis F. Y.; Savvatakis, Konstantinos; Topping, Geoffrey J.; Englert, Florian; Kritzner, Lukas; Grashei, Martin; Tannapfel, Andrea; Viebahn, Richard; Wolters, Heiner; Uhl, Waldemar; Vangala, Deepak; Smeets, Esther M. M.; Aarntzen, Erik H. J. G.; Rauh, Daniel; Weichert, Wilko; Hoheisel, Jörg D.; Hahn, Stephan A.; Schilling, Franz; Braren, Rickmer; Trajkovic-Arsic, Marija; Siveke, Jens
    Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma
    In: Cancer & Metabolism Jg. 10 (2022) Nr. 1, 24
  • Heilig, Christoph E.; Laßmann, Andreas; Mughal, Sadaf S.; Mock, Andreas; Pirmann, Sebastian; Teleanu, Veronica; Renner, Marcus; Andresen, Carolin; Köhler, Bruno C.; Aybey, Bogac; Bauer, Sebastian; Siveke, Jens; Hamacher, Rainer; Folprecht, Gunnar; Richter, Stephan; Schröck, Evelin; Brandts, Christian H.; Ahrens, Marit; Hohenberger, Peter; Egerer, Gerlinde; Kindler, Thomas; Boerries, Melanie; Illert, Anna L.; von Bubnoff, Nikolas; Apostolidis, Leonidas; Jost, Philipp J.; Westphalen, C. Benedikt; Weichert, Wilko; Keilholz, Ulrich; Klauschen, Frederick; Beck, Katja; Winter, Ulrike; Richter, Daniela; Möhrmann, Lino; Bitzer, Michael; Schulze-Osthoff, Klaus; Brors, Benedikt; Mechtersheimer, Gunhild; Kreutzfeldt, Simon; Heining, Christoph; Lipka, Daniel B.; Stenzinger, Albrecht; Schlenk, Richard F.; Horak, Peter; Glimm, Hanno; Hübschmann, Daniel; Fröhling, Stefan
    Gene expression-based prediction of pazopanib efficacy in sarcoma
    In: European Journal of Cancer (EJC) Jg. 172 (2022) S. 107 - 118
  • Ferdinandus, Justin; Costa, Pedro Fragoso; Kessler, Lukas; Weber, Manuel; Hirmas, Nader; Kostbade, Karina; Bauer, Sebastian; Schuler, Martin; Ahrens, Marit; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Grafe, Hong; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang; Hamacher, Rainer
    Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors : A Case Series of 9 Patients
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 727 - 734
  • Reissig, Timm M.; Uhrig, Sebastian; Jost, Philipp J.; Luchini, Claudio; Vicentini, Caterina; Liffers, Sven-Thorsten; Allgäuer, Michael; Adsay, Volkan; Scarpa, Aldo; Lawlor, Rita Teresa; Fröhling, Stefan; Stenzinger, Albrecht; Klöppel, Günter; Schildhaus, Hans-Ulrich; Siveke, Jens
    MCL1 as putative target in pancreatoblastoma
    In: Virchows Archiv Jg. 481 (2022) Nr. 2, S. 265 - 272
  • Keyl, J.; Kasper, S.; Wiesweg, Marcel; Götze, J.; Schönrock, M.; Sinn, M.; Berger, A.; Nasca, E.; Kostbade, K.; Schumacher, B.; Markus, P.; Treckmann, Jürgen-Walter; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Siveke, Jens; Schuler, Martin; Kleesiek, J.
    Multimodal survival prediction in advanced pancreatic cancer using machine learning
    In: ESMO Open Jg. 7 (2022) Nr. 5, 100555
  • Lorenzen, Sylvie; Quante, Michael; Rauscher, Isabel; Slotta-Huspenina, Julia; Weichert, Wilko; Feith, Marcus; Friess, Helmut; Combs, Stefanie E.; Weber, Wolfgang A.; Haller, Bernhard; Angele, Martin; Albertsmeier, Markus; Blankenstein, Christiane; Kasper, Stefan; Schmid, Roland M.; Bassermann, Florian; Schwaiger, Markus; Liffers, Sven-Thorsten; Siveke, Jens
    PET-directed combined modality therapy for gastroesophageal junction cancer : Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK)
    In: European Journal of Cancer (EJC) Jg. 175 (2022) S. 99 - 106
  • Högner, Anica; Al-Batran, Salah-Eddin; Siveke, Jens; Lorenz, Mario; Bartels, Prisca; Breithaupt, Kirstin; Malfertheiner, Peter; Homann, Nils; Stein, Alexander; Gläser, Dietrich; Tamm, Ingo; Hinke, Axel; Vogel, Arndt; Thuss-Patience, Peter
    Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer : A randomized phase-II study - The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510
    In: International Journal of Cancer Jg. 150 (2022) Nr. 6, S. 1007 - 1017
  • Bazhin, Alexandr V.; von Ahn, Katharina; Fritz, Jasmin; Bunge, Henriette; Maier, Caroline; Isayev, Orkhan; Neff, Florian; Siveke, Jens; Karakhanova, Svetlana
    Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer
    In: OncoImmunology Jg. 11 (2022) Nr. 1, 2043037
  • Kruger, S.F.; Lohneis, A.; Abendroth, A.; Berger, A.W.; Ettrich, T.J.; Waidmann, O.; Kapp, M.; Steiner, B.; Kumbrink, J.; Reischer, A.; Haas, M.; Westphalen, C.B.; Zhang, D.; Miller-Phillips, L.; Burger, P.J.; Kobold, S.; Werner, J.; Subklewe, M.; von Bergwelt-Baildon, M.; Kunzmann, V.; Seufferlein, T.; Siveke, Jens; Sinn, M.; Heinemann, V.; Ormanns, S.; Boeck, S.
    Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases : translational results from the German multicenter AIO-YMO-PAK-0515 study
    In: ESMO Open Jg. 7 (2022) Nr. 1, 100388
  • Hartlapp, I.; Valta-Seufzer, D.; Siveke, Jens T.; Algül, H.; Goekkurt, E.; Siegler, G.; Martens, U.M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T.J.; Held, S.; Keller, R.; Anger, F.; Germer, C.T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V.
    Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy : results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)
    In: ESMO Open Jg. 7 (2022) Nr. 4, 100552
  • Cheung, Phyllis F.; Yang, JiaJin; Fang, Rui; Borgers, Arianna; Krengel, Kirsten; Stoffel, Anne; Althoff, Kristina; Yip, Chi Wai; Siu, Elaine H. L.; Ng, Linda W. C.; Lang, Karl S.; Cham, Lamin B.; Engel, Daniel Robert; Soun, Camille; Cima, Igor; Scheffler, Björn; Striefler, Jana K.; Sinn, Marianne; Bahra, Marcus; Pelzer, Uwe; Oettle, Helmut; Markus, Peter; Smeets, Esther M. M.; Aarntzen, Erik H. J. G.; Savvatakis, Konstantinos; Liffers, Sven-Thorsten; Lueong, Smiths S.; Neander, Christian; Bazarna, Anna; Zhang, Xin; Paschen, Annette; Crawford, Howard C.; Chan, Anthony W. H.; Cheung, Siu Tim; Siveke, Jens
    Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression
    In: Nature Communications Jg. 13 (2022) Nr. 1, 156
  • Zensen, Sebastian; Opitz, Marcel K.; Ludwig, Johannes M.; Haubold, Johannes; Richly, Heike; Siveke, Jens; Theysohn, Jens; Forsting, Michael; Bos, Denise; Schaarschmidt, Benedikt M.
    Radiation Dose Aspects of Hepatic Artery Infusion Chemotherapy in Uveal Melanoma Patients with Liver Metastases
    In: Cardiovascular and Interventional Radiology Jg. 45 (2022) Nr. 6, S. 841 - 845
  • Fendler, Wolfgang; Pabst, Kim M.; Kessler, Lukas; Fragoso Costa, Pedro; Ferdinandus, Justin; Weber, Manuel; Lippert, Maria; Lückerath, Katharina; Umutlu, Lale; Kostbade, Karina; Mavroeidi, Ilektra A.; Schuler, Martin; Ahrens, Marit; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens; Hamacher, Rainer
    Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
    In: Clinical Cancer Research Jg. 28 (2022) Nr. 19, S. 4346 - 4353
  • Metzenmacher, Martin; Hegedüs, Balazs; Forster, Jan; Schramm, Alexander; Horn, Peter; Klein, Christoph A.; Bielefeld, Nicola; Ploenes, Till; Aigner, Clemens; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    The clinical utility of cfRNA for disease detection and surveillance : A proof of concept study in non-small cell lung cancer
    In: Thoracic Cancer (2022) in press
  • Guberina, Nika; Kessler, Lukas; Pöttgen, Christoph; Guberina, Maja; Metzenmacher, Martin; Herrmann, Ken; Mucha, Maja; Rischpler, Christoph; Indenkämpen, Frank; Siveke, Jens; Treckmann, Jürgen-Walter; Umutlu, Lale; Kasper, Stefan; Fendler, Wolfgang; Stuschke, Martin
    ⁶⁸Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
    In: Scientific Reports Jg. 12 (2022) Nr. 1, 16261
  • Niersch, Jennifer; Vega-Rubín-de-Celis, Silvia; Bazarna, Anna; Mergener, Svenja; Jendrossek, Verena; Siveke, Jens; Peña-Llopis, Samuel
    A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis
    In: iScience Jg. 24 (2021) Nr. 3, 102173
  • Rosery, Vivian; Reis, Henning; Savvatakis, Konstantinos; Kowall, Bernd; Stuschke, Martin; Paul, Andreas; Dechene, Alexander; Yang, JiaJin; Zhao, Ben; Borgers, Arianna; Kasper, Stefan; Schuler, Martin; Cheung, Phyllis F.; Siveke, Jens
    Antitumor immune response is associated with favorable survival in GEP-NEN G3
    In: Endocrine-Related Cancer Jg. 28 (2021) Nr. 10, S. 683 - 693
  • Bliemsrieder, Elisabeth; Kaissis, Georgios; Grashei, Martin; Topping, Geoffrey; Altomonte, Jennifer; Hundshammer, Christian; Lohöfer, Fabian; Heid, Irina; Keim, Dominik; Gebrekidan, Selamawit; Trajkovic-Arsic, Marija; Winkelkotte, Am; Steiger, Katja; Nawroth, Roman; Siveke, Jens; Schwaiger, Markus; Makowski, Marcus; Schilling, Franz; Braren, Rickmer
    Author Correction: Hyperpolarized ¹³C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC
    In: Scientific Reports Jg. 11 (2021) Nr. 1, 11705
  • Siebermair, Johannes; Köhler, Miriam; Kupusovic, Jana; Nekolla, Stephan Gerhard; Kessler, Lukas; Ferdinandus, Justin; Guberina, Nika; Stuschke, Martin; Grafe, Hong; Siveke, Jens; Kochhäuser, Simon; Fendler, Wolfgang Peter; Totzeck, Matthias; Wakili, Reza; Umutlu, Lale; Schlosser, Thomas Wilfried; Rassaf, Tienush; Rischpler, Christoph
    Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodeling
    In: Journal of Nuclear Cardiology Jg. 28 (2021) Nr. 3, S. 812 - 821
  • Quambusch, Lena; Depta, Laura; Landel, Ina; Lubeck, Melissa; Kirschner, Tonia; Nabert, Jonas; Uhlenbrock, Niklas; Weisner, Jörn; Kostka, Michael; Levy, Laura M.; Schultz-Fademrecht, Carsten; Glanemann, Franziska; Althoff, Kristina; Müller, Matthias P.; Siveke, Jens; Rauh, Daniel
    Cellular model system to dissect the isoform-selectivity of Akt inhibitors
    In: Nature Communications Jg. 12 (2021) Nr. 1, 5297
  • Markus, M.; Abendroth, Annalena; Noureddine, R.; Paul, Andreas; Breitenbuecher, Sandra; Virchow, Isabel; Schmid, Kurt Werner; Markus, Peter; Schumacher, Brigitte M.; Wiesweg, Marcel; Wendling, Johanna; Mende, Bastian; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology Jg. 147 (2021) Nr. 2, S. 579 - 591
  • Horak, Peter; Heining, Christoph; Kreutzfeldt, Simon; Hutter, Barbara; Mock, Andreas; Hüllein, Jennifer; Fröhlich, Martina; Uhrig, Sebastian; Jahn, Arne; Rump, Andreas; Gieldon, Laura; Möhrmann, Lino; Hanf, Dorothea; Teleanu, Veronica; Heilig, Christoph E.; Lipka, Daniel B.; Allgäuer, Michael; Ruhnke, Leo; Laßmann, Andreas; Endris, Volker; Neumann, Olaf; Penzel, Roland; Beck, Katja; Richter, Daniela; Winter, Ulrike; Wolf, Stephan; Pfütze, Katrin; Geörg, Christina; Meißburger, Bettina; Buchhalter, Ivo; Augustin, Marinela; Aulitzky, Walter E.; Hohenberger, Peter; Kroiss, Matthias; Schirmacher, Peter; Schlenk, Richard F.; Keilholz, Ulrich; Klauschen, Frederick; Folprecht, Gunnar; Bauer, Sebastian; Siveke, Jens; Brandts, Christian H.; Kindler, Thomas; Boerries, Melanie; Illert, Anna L.; von Bubnoff, Nikolas; Jost, Philipp J.; Spiekermann, Karsten; Bitzer, Michael; Schulze-Osthoff, Klaus; von Kalle, Christof; Klink, Barbara; Brors, Benedikt; Stenzinger, Albrecht; Schröck, Evelin; Hübschmann, Daniel; Weichert, Wilko; Glimm, Hanno; Fröhling, Stefan
    Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
    In: Cancer Discovery Jg. 11 (2021) Nr. 11, S. 2780 - 2795
  • Reißig, Timm; Siveke, Jens
    Duktales Adenokarzinom des Pankreas : Entstehung, Diagnostik, Therapie
    In: Der Gastroenterologe Jg. 16 (2021) Nr. 1, S. 41 - 50
  • Chen, Li-Tzong; Macarulla, Teresa; Blanc, Jean-Frédéric; Mirakhur, Beloo; de Jong, Floris A.; Belanger, Bruce; Bekaii-Saab, Tanios; Siveke, Jens
    Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC) : A post hoc analysis of NAPOLI-1
    In: Pancreatology Jg. 21 (2021) Nr. 1, S. 192 - 199
  • Pohl, Julia; Mincu, Raluca-Ileana; Mrotzek, Simone; Wakili, Reza; Mahabadi, Amir Abbas; Potthoff, Sophia K.; Siveke, Jens; Keller, Ulrich; Landmesser, Ulf; Rassaf, Tienush; Anker, Markus S.; Totzeck, Matthias
    Ecg scoring for the evaluation of therapy-naïve cancer patients to predict cardiotoxicity
    In: Cancers Jg. 13 (2021) Nr. 6, S. 1197
  • Bliemsrieder, Elisabeth; Kaissis, Georgios; Grashei, Martin; Topping, Geoffrey; Altomonte, Jennifer; Hundshammer, Christian; Lohöfer, Fabian; Heid, Irina; Keim, Dominik; Gebrekidan, Selamawit; Trajkovic-Arsic, Marija; Winkelkotte, Aline; Steiger, Katja; Nawroth, Roman; Siveke, Jens; Schwaiger, Markus; Makowski, Marcus; Schilling, Franz; Braren, Rickmer
    Hyperpolarized ¹³C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC
    In: Scientific Reports Jg. 11 (2021) Nr. 1, 1191
  • Ludwig, Johannes; Haubold, Johannes; Heusner, Till Alexander; Bauer, Sebastian; Siveke, Jens; Richly, Heike; Wetter, Axel; Umutlu, Lale; Theysohn, Jens
    Laktatdehydrogenase vor transarterieller hepatischer Chemoperfusion prognostiziert das Überleben und den Tumorprogress bei Patienten mit Lebermetastasen bei Aderhautmelanom
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren Jg. 193 (2021) Nr. 06, S. 683 - 691
  • Schott, Inna; Liffers, Sven-Thorsten; Farzaliyev, Farhad; Falkenhorst, Johanna; Steinau, Hans-Ulrich; Treckmann, Jürgen-Walter; Podleska, Lars; Pöttgen, Christoph; Schildhaus, Hans-Ulrich; Ahrens, Marit; Dirksen, Uta; Murat, Fatma-Zehra; Siveke, Jens; Bauer, Sebastian; Hamacher, Rainer
    Localized Angiosarcoma, Not One Disease : A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology
    In: Sarcoma Jg. 2021 (2021) 9960085
  • Brägelmann, Johannes; Lorenz, Carina; Borchmann, Sven; Nishii, Kazuya; Wegner, Julia; Meder, Lydia; Ostendorp, Jenny; Ast, David F.; Heimsoeth, Alena; Nakasuka, Takamasa; Hirabae, Atsuko; Okawa, Sachi; Dammert, Marcel A.; Plenker, Dennis; Klein, Sebastian; Lohneis, Philipp; Gu, Jianing; Godfrey, Laura K.; Forster, Jan; Trajkovic-Arsic, Marija; Zillinger, Thomas; Haarmann, Mareike; Quaas, Alexander; Lennartz, Stefanie; Schmiel, Marcel; D’Rozario, Joshua; Thomas, Emily S.; Li, Henry; Schmitt, Clemens A.; George, Julie; Thomas, Roman K.; von Karstedt, Silvia; Hartmann, Gunther; Büttner, Reinhard; Ullrich, Roland T.; Siveke, Jens; Ohashi, Kadoaki; Schlee, Martin; Sos, Martin L.
    MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I
    In: Nature Communications Jg. 12 (2021) Nr. 1, 5505
  • Mergener, Svenja; Siveke, Jens; Peña-Llopis, Samuel
    Monosomy 3 is linked to resistance to mek inhibitors in uveal melanoma
    In: International Journal of Molecular Sciences (IJMS) Jg. 22 (2021) Nr. 13, 6727
  • Reißig, Timm M.; Siveke, Jens
    Multimodale Therapie ampullärer Karzinome
    In: Der Chirurg Jg. 92 (2021) Nr. 9, S. 803 - 808
  • Kunzmann, Volker; Siveke, Jens; Algül, Hana; Goekkurt, Eray; Siegler, Gabriele; Martens, Uwe; Waldschmidt, Dirk; Pelzer, Uwe; Fuchs, Martin; Kullmann, Frank; Boeck, Stefan; Ettrich, Thomas J; Held, Swantje; Keller, Ralph; Klein, Ingo; Germer, Christoph-Thomas; Stein, Hubert; Friess, Helmut; Bahra, Marcus; Jakobs, Ralf; Hartlapp, Ingo; Heinemann, Volker; German Pancreatic Cancer Working Group (AIO-PAK) and NEOLAP investigators; Stahl, Michael; Mahlmann, Stefan
    Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113) : a multicentre, randomised, phase 2 trial
    In: The Lancet Gastroenterology & Hepatology Jg. 6 (2021) Nr. 2, S. 128 - 138
  • Sun, Na; Trajkovic-Arsic, Marija; Li, Fengxia; Wu, Yin; Münch, Corinna; Kunzke, Thomas; Feuchtinger, Annette; Steiger, Katja; Schlitter, Anna Melissa; Weichert, Wilko; Esposito, Irene; Siveke, Jens T.; Walch, Axel
    Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma
    In: EJNMMI Research Jg. 11 (2021) Nr. 1, 120
  • Singh, Hans Martin; Bailey, Peter; Hübschmann, Daniel; Berger, Anne Katrin; Neoptolemos, John P.; Jäger, Dirk; Siveke, Jens; Springfeld, Christoph
    Poly(ADP-ribose) polymerase inhibition in pancreatic cancer
    In: Genes, Chromosomes and Cancer Jg. 60 (2021) Nr. 5, S. 373 - 384
  • Ludwig, Johannes M.; Haubold, Johannes; Bauer, Sebastian; Richly, Heike; Siveke, Jens; Wimmer, Julia; Umutlu, Lale; Schaarschmidt, Benedikt M.; Theysohn, Jens
    Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion
    In: Radiology and Oncology Jg. 55 (2021) Nr. 3, S. 347 - 353
  • Vangala, Deepak; Ladigan, Swetlana; Liffers, Sven T.; Noseir, Soha; Maghnouj, Abdelouahid; Götze, Tina-Maria; Verdoodt, Berlinda; Klein-Scory, Susanne; Godfrey, Laura; Zowada, Martina K.; Huerta, Mario; Edelstein, Daniel L.; de Villarreal, Jaime Martinez; Marqués, Miriam; Kumbrink, Jörg; Jung, Andreas; Schiergens, Tobias; Werner, Jens; Heinemann, Volker; Stintzing, Sebastian; Lindoerfer, Doris; Mansmann, Ulrich; Pohl, Michael; Teschendorf, Christian; Bernhardt, Christiane; Wolters, Heiner; Stern, Josef; Usta, Selami; Viebahn, Richard; Admard, Jacob; Casadei, Nicolas; Fröhling, Stefan; Ball, Claudia R.; Siveke, Jens T.; Glimm, Hanno; Tannapfel, Andrea; Schmiegel, Wolff; Hahn, Stephan A.
    Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
    In: Genome Medicine Jg. 13 (2021) Nr. 1, 116
  • Dorsch, Madeleine; Kowalczyk, Manuela; Planque, Mélanie; Heilmann, Geronimo; Urban, Sebastian; Dujardin, Philip; Forster, Jan; Ueffing, Kristina; Nothdurft, Silke; Oeck, Sebastian; Paul, Annika; Liffers, Sven T.; Kaschani, Farnusch; Kaiser, Markus; Schramm, Alexander; Siveke, Jens; Winslow, Monte M.; Fendt, Sarah-Maria; Nalbant, Perihan; Grüner, Barbara M.
    Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis
    In: Cell Reports Jg. 37 (2021) Nr. 8, 110056
  • Altmann, Annette; Haberkorn, Uwe; Siveke, Jens
    The Latest Developments in Imaging of Fibroblast Activation Protein
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 2, S. 160 - 167
  • Ahmadov, Ulvi; Picard, Daniel; Bartl, Jasmin; Silginer, Manuela; Trajkovic-Arsic, Marija; Qin, Nan; Blümel, Lena; Wolter, Marietta; Lim, Jonathan K. M.; Pauck, David; Winkelkotte, Alina Marie; Melcher, Marlen; Langini, Maike; Marquardt, Viktoria; Sander, Felix; Stefanski, Anja; Steltgens, Sascha; Hassiepen, Christina; Kaufhold, Anna; Meyer, Frauke-Dorothee; Seibt, Annette; Kleinesudeik, Lara; Hain, Anika; Münk, Carsten; Knobbe-Thomsen, Christiane Brigitte; Schramm, Alexander; Fischer, Ute; Leprivier, Gabriel; Stühler, Kai; Fulda, Simone; Siveke, Jens; Distelmaier, Felix; Borkhardt, Arndt; Weller, Michael; Roth, Patrick; Reifenberger, Guido; Remke, Marc
    The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma
    In: Cell Death and Disease Jg. 12 (2021) Nr. 10, 885
  • Váraljai, Renáta; Elouali, S.; Lueong, Smiths S.; Wistuba-Hamprecht, Kilian; Seremet, Teofila C.; Siveke, Jens; Becker, Jürgen; Sucker, Antje; Paschen, Annette; Horn, Peter; Neyns, Bart; Weide, Benjamin M.; Schadendorf, Dirk; Rösch, Alexander
    The predictive and prognostic significance of cell-free DNA concentration in melanoma
    In: Journal of the European Academy of Dermatology and Venereology Jg. 35 (2021) Nr. 2, S. 387 - 395
  • Lu, I-Na; Dobersalske, Celia; Rauschenbach, Laurèl; Teuber-Hanselmann, Sarah; Steinbach, Anita; Ullrich, Vivien; Prasad, Shruthi; Blau, Tobias; Kebir, Sied; Siveke, Jens; Becker, Jürgen; Sure, Ulrich; Glas, Martin; Scheffler, Björn; Cima, Igor
    Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression
    In: Nature Communications Jg. 12 (2021) Nr. 1, 3895
  • Harder, Felix N.; Jungmann, Friederike; Kaissis, Georgios A.; Lohöfer, Fabian K.; Ziegelmayer, Sebastian; Havel, Daniel; Quante, Michael; Reichert, Maximillian; Schmid, Roland M.; Demir, Ihsan Ekin; Friess, Helmut; Wildgruber, Moritz; Siveke, Jens; Muckenhuber, Alexander; Steiger, Katja; Weichert, Wilko; Rauscher, Isabel; Eiber, Matthias; Makowski, Marcus R.; Braren, Rickmer F.
    [¹⁸F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma
    In: EJNMMI Research Jg. 11 (2021) Nr. 1, 70
  • Johansson, Patricia; Dierichs, Laura; Klein-Hitpaß, Ludger; Bergmann, Anke K.; Möllmann, Michael; Menninger, Sascha; Habenberger, Peter; Klebl, Bert; Siveke, Jens; Dührsen, Ulrich; Choidas, Axel; Dürig, Jan
    Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia
    In: Therapeutic Advances in Hematology Jg. 11 (2020) S. 1 - 15
  • Zhang, Xin; Zegar, Tim; Weiser, Tim; Hamdan, Feda H.; Berger, Benedict-Tilman; Lucas, Romain; Balourdas, Dimitrios-IIias; Ladigan, Swetlana; Cheung, Phyllis F.; Liffers, Sven-Thorsten; Trajkovic-Arsic, Marija; Scheffler, Björn; Joerger, Andreas C.; Hahn, Stephan A.; Johnsen, Steven A.; Knapp, Stefan; Siveke, Jens
    Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma
    In: International Journal of Cancer Jg. 147 (2020) Nr. 10, S. 2847 - 2861
  • Westphalen, Benedikt C.; Bokemeyer, Carsten; Schilling, Bastian; Siveke, Jens T.; Loges, Sonja; Schadendorf, Dirk; Schildhaus, Hans-Ulrich
    Conceptual framework for precision cancer medicine in Germany : Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’
    In: European Journal of Cancer (EJC) Jg. 135 (2020) S. 1 - 7
  • Reißig, Timm; Siveke, Jens
    Duktales Adenokarzinom des Pankreas : Entstehung, Diagnostik, Therapie
    In: Der Onkologe Jg. 26 (2020) Nr. 10, S. 977 - 985
  • Scherr, Anna-Lena; Mock, Andreas; Gdynia, Georg; Schmitt, Nathalie; Heilig, Christoph E.; Korell, Felix; Rhadakrishnan, Praveen; Hoffmeister, Paula; Metzeler, Klaus H.; Schulze-Osthoff, Klaus; Illert, Anna L.; Boerries, Melanie; Trojan, Jörg; Waidmann, Oliver; Falkenhorst, Johanna; Siveke, Jens; Jost, Philipp J.; Bitzer, Michael; Malek, Nisar P.; Vecchione, Loredana; Jelas, Ivan; Brors, Benedikt; Glimm, Hanno; Stenzinger, Albrecht; Grekova, Svetlana P.; Gehrig, Tobias; Schulze-Bergkamen, Henning; Jäger, Dirk; Schirmacher, Peter; Heikenwalder, Mathias; Goeppert, Benjamin; Schneider, Martin; Fröhling, Stefan; Köhler, Bruno C.
    Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
    In: Cell Death and Disease Jg. 11 (2020) Nr. 10, 875
  • Kaissis, Georgios A.; Ziegelmayer, Sebastian; Lohöfer, Fabian K.; Harder, Felix N.; Jungmann, Friederike; Sasse, Daniel; Muckenhuber, Alexander; Yen, Hsi-Yu; Steiger, Katja; Siveke, Jens; Friess, Helmut; Schmid, Roland; Weichert, Wilko; Makowski, Marcus R.; Braren, Rickmer F.
    Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma
    In: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 3, 724
  • Dantes, Zahra; Yen, Hsi-Yu; Pfarr, Nicole; Winter, Christof; Steiger, Katja; Muckenhuber, Alexander; Hennig, Alexander; Lange, Sebastian; Engleitner, Thomas; Öllinger, Rupert; Maresch, Roman; Orben, Felix; Heid, Irina; Kaissis, Georgios; Shi, Kuangyu; Topping, Geoffrey; Stögbauer, Fabian; Wirth, Matthias; Peschke, Katja; Papargyriou, Aristeidis; Rezaee-Oghazi, Massoud; Feldmann, Karin; Schäfer, Arlett P.G.; Ranjan, Raphela; Lubeseder-Martellato, Clara; Stange, Daniel E.; Welsch, Thilo; Martignoni, Marc; Ceyhan, Güralp O.; Friess, Helmut; Herner, Alexander; Liotta, Lucia; Treiber, Matthias; von Figura, Guido; Abdelhafez, Mohamed; Klare, Peter; Schlag, Christoph; Algül, Hana; Siveke, Jens; Braren, Rickmer; Weirich, Gregor; Weichert, Wilko; Saur, Dieter; Rad, Roland; Schmid, Roland M.; Schneider, Günter; Reichert, Maximilian
    Implementing cell-free DNA of pancreatic cancer patient–derived organoids for personalized oncology
    In: JCI Insight Jg. 5 (2020) Nr. 15, S. e137809
  • MacArulla Mercadé, Teresa; Chen, Li-Tzong; Li, Chung-Pin; Siveke, Jens; Cunningham, David; Bodoky, György; Blanc, Jean-Frédéric; Lee, Kyung-Hun; Dean, Andrew; Belanger, Bruce; Wang-Gillam, Andrea
    Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer : Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial
    In: Pancreas Jg. 49 (2020) Nr. 1, S. 62 - 75
  • Hidalgo-Sastre, Ana; Desztics, Judit; Dantes, Zahra; Schulte, Katharina; Ensarioglu, Hilal Kabadayi; Bassey-Archibong, Blessing; Öllinger, Rupert; Engleiter, Thomas; Rayner, Lyndsay; Einwächter, Henrik; Daniel, Juliet M.; Altaee, Ali Sameer Abdulghani; Steiger, Katia; Lesina, Marina; Rad, Roland; Reichert, Maximilian; Von Figura, Guido; Siveke, Jens; Schmid, Roland M.; Lubeseder-Martellato, Clara
    Loss of Wasl improves pancreatic cancer outcome
    In: JCI Insight Jg. 5 (2020) Nr. 10, e127275
  • Hidalgo-Sastre, Ana; Lubeseder-Martellato, Clara; Engleitner, Thomas; Steiger, Katja; Zhong, Suyang; Desztics, Judit; Öllinger, Rupert; Rad, Roland; Schmid, Roland M.; Hermeking, Heiko; Siveke, Jens; von Figura, Guido
    Mir34a constrains pancreatic carcinogenesis
    In: Scientific Reports Jg. 10 (2020) Nr. 1, S. 9654
  • Tjaden, Britta; Baum, Katharina; Marquardt, Viktoria; Simon, Mareike; Trajkovic-Arsic, Marija; Kouril, Theresa; Siebers, Bettina; Lisec, Jan; Siveke, Jens; Schulte, Johannes H.; Benary, Uwe; Remke, Marc; Wolf, Jana; Schramm, Alexander
    N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
    In: Scientific Reports Jg. 10 (2020) Nr. 1, S. 7157
  • Bodei, Lisa; Bergsland, Emily; de Herder, Wouter W.; Ferone, Diego; Hicks, Rodney J.; Hope, Thomas A.; Kunikowska, Jolanta; Pavel, Marianne; Reidy-Lagunes, Diane; Siveke, Jens; Strosberg, Jonathan; Dittmer, Ulf; Herrmann, Ken
    Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic : Are There Any Concerns?
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 8, S. 1094 - 1095
  • Lorenzen, Sylvie; Knorrenschild, Jorge Riera; Pauligk, Claudia; Hegewisch-Becker, Susanna; Seraphin, Jörg; Thuss-Patience, Peter; Kopp, Hans-Georg; Dechow, Tobias; Vogel, Arndt; Luley, Kim Barbara; Pink, Daniel; Stahl, Michael; Kullmann, Frank; Hebart, Holger; Siveke, Jens; Egger, Matthias; Homann, Nils; Probst, Stephan; Goetze, Thorsten Oliver; Al-Batran, Salah-Eddin
    Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC)
    In: International Journal of Cancer Jg. 147 (2020) Nr. 9, S. 2493 - 2502
  • Metzenmacher, Martin; Váraljai, Renáta; Hegedüs, Balazs; Cima, Igor; Forster, Jan; Schramm, Alexander; Scheffler, Björn; Horn, Peter; Klein, Christoph A.; Szarvas, Tibor; Reis, Henning; Bielefeld, Nicola; Rösch, Alexander; Aigner, Clemens; Kunzmann, Volker; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancer
    In: Cancers Jg. 12 (2020) Nr. 2, S. 353
  • Szymonowicz, Klaudia; Krysztofiak, Adam; van der Linden, Jansje; Kern, Ajvar; Deycmar, Simon; Oeck, Sebastian; Squire, Anthony; Koska, Benjamin; Hlouschek, Julian; Vüllings, Melanie; Neander, Christian; Siveke, Jens; Matschke, Johann; Pruschy, Martin; Timmermann, Beate; Jendrossek, Verena
    Proton Irradiation Increases the Necessity for Homologous Recombination Repair Along with the Indispensability of Non-Homologous End Joining
    In: Cells Jg. 9 (2020) Nr. 4, S. 889
  • Lueong, Smiths S; Herbst, Andreas; Liffers, Sven-Thorsten; Bielefeld, Nicola; Horn, Peter; Tannapfel, Andrea; Reinacher-Schick, Anke; Hinke, Axel; Hegewisch-Becker, Susanna; Kolligs, Frank T; Siveke, Jens
    Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial
    In: Clinical Chemistry Jg. 66 (2020) Nr. 12, S. 1510 - 1520
  • Zhao, Ben; Dierichs, Laura; Gu, Jiang-Ning; Trajkovic-Arsic, Marija; Axel Hilger, Ralf; Savvatakis, Konstantinos; Vega-Rubín-de-Celis, Silvia; Liffers, Sven-Thorsten; Peña-Llopis, Samuel; Behrens, Diana; Hahn, Stephan; Siveke, Jens; Lueong, Smiths S.
    TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer
    In: Cell Death Discovery Jg. 6 (2020) Nr. 1, 12
  • Miao, Beiping; Bauer, Andrea S.; Hufnagel, Katrin; Wu, Yenan; Trajkovic-Arsic, Marija; Pirona, Anna C.; Giese, Nathalia; Taipale, Jussi; Siveke, Jens; Hoheisel, Jörg D.; Lueong, Smiths
    The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation
    In: International Journal of Cancer Jg. 147 (2020) Nr. 1, S. 189 - 201
  • Zhang, Xin; Zegar, Tim; Lucas, Anais; Morrison-Smith, Chevaun; Knox, Tatiana; French, Christopher A.; Knapp, Stefan; Müller, Susanne; Siveke, Jens
    Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
    In: Oncogene Jg. 39 (2020) Nr. 24, S. 4770 - 4779
  • Schug, Christina; Gupta, Aayush; Urnauer, Sarah; Steiger, Katja; Cheung, Phyllis Fung-Yi; Neander, Christian; Savvatakis, Konstantinos; Schmohl, Kathrin A.; Trajkovic-Arsic, Marija; Schwenk, Nathalie; Schwaiger, Markus; Nelson, Peter J.; Siveke, Jens; Spitzweg, Christine
    A Novel Approach for Image-Guided I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery
    In: Molecular Cancer Research Jg. 17 (2019) Nr. 1, S. 310 - 320
  • Kaissis, Georgios; Ziegelmayer, Sebastian; Lohöfer, Fabian; Steiger, Katja; Algül, Hana; Muckenhuber, Alexander; Yen, Hsi-Yu; Rummeny, Ernst; Friess, Helmut; Schmid, Roland; Weichert, Wilko; Siveke, Jens; Braren, Rickmer
    A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy
    In: PLoS ONE Jg. 14 (2019) Nr. 10, S. e0218642
  • Kaissis, Georgios; Ziegelmayer, Sebastian; Lohöfer, Fabian; Algül, Hana; Eiber, Matthias; Weichert, Wilko; Schmid, Roland; Friess, Helmut; Rummeny, Ernst; Ankerst, Donna; Siveke, Jens; Braren, Rickmer
    A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging
    In: European Radiology Experimental Jg. 3 (2019) Nr. 1, 41
  • Quambusch, Lena; Landel, Ina; Depta, Laura; Weisner, Jörn; Uhlenbrock, Niklas; Müller, Matthias P.; Glanemann, Franziska; Althoff, Kristina; Siveke, Jens; Rauh, Daniel
    Covalent-Allosteric Inhibitors to Achieve Akt Isoform-Selectivity
    In: Angewandte Chemie International Edition Jg. 58 (2019) Nr. 52, S. 18823 - 18829
  • Macarulla, Teresa; Blanc, Jean-Frédéric; Wang-Gillam, Andrea; Chen, Li-Tzong; Siveke, Jens; Mirakhur, Beloo; Chen, Jie; Jong, Floris A. de
    Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer : a subgroup analysis of the pivotal NAPOLI-1 trial
    In: Journal of Geriatric Oncology Jg. 10 (2019) Nr. 3, S. 427 - 435
  • Walter, Karolin; Tiwary, Kanishka; Trajkovic-Arsic, Marija; Hidalgo-Sastre, Ana; Dierichs, Laura; Liffers, Sven T.; Gu, Jiangning; Gout, Johann; Schulte, Lucas-Alexander; Münch, Jan; Seufferlein, Thomas; Sainz, Bruno; Siveke, Jens; Rodriguez-Aznar, Eva; Hermann, Patrick C.
    MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo
    In: Stem Cells International Jg. 2019 (2019) S. 8475389
  • Wang-Gillam, Andrea; Hubner, Richard A.; Siveke, Jens T.; Hoff, Daniel D. von; Belanger, Bruce; Jong, Floris A. de; Mirakhur, Beloo; Chen, Li-Tzong
    NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer : Final overall survival analysis and characteristics of long-term survivors
    In: European Journal of Cancer (EJC) Jg. 108 (2019) S. 78 - 87
  • Westphalen, C. Benedikt; Preinfalk, A.; Kruger, S.; Haas, M.; Renz, B. W.; Riener, M.-O.; Weber, A.; Kirchner, T.; Werner, J.; Heinemann, V.; Bergwelt-Baildon, M. von; Baba, Hideo Andreas; Siveke, Jens; Ormanns, S.; Boeck, S.
    Neurotrophic tropomyosin receptor kinase (NTRK) and nerve growth factor (NGF) are not expressed in Caucasian patients with biliary tract cancers : pooled data from three independent cohorts
    In: Clinical and Translational Oncology Jg. 21 (2019) Nr. 8, S. 1108 - 1111
  • Chen, Li-Tzong; Macarulla, Teresa; Blanc, Jean-Frédéric; Mirakhur, Beloo; Jong, Floris A. de; Belanger, Bruce; Bekaii-Saab, Tanios; Siveke, Jens
    Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer
    In: Cancers Jg. 11 (2019) Nr. 8, S. 1068
  • Weisner, Jörn; Landel, Ina; Reintjes, Christoph; Uhlenbrock, Niklas; Trajkovic-Arsic, Marija; Dienstbier, Niklas; Hardick, Julia; Ladigan, Swetlana; Lindemann, Marius; Smith, Steven; Quambusch, Lena; Scheinpflug, Rebekka; Depta, Laura; Gontla, Rajesh; Unger, Anke; Müller, Heiko; Baumann, Matthias; Schultz-Fademrecht, Carsten; Gunther, Georgia; Maghnouj, Abdelouahid; Müller, Matthias P.; Pohl, Michael; Teschendorf, Christian; Wolters, Heiner; Viebahn, Richard; Tannapfel, Andrea; Uhl, Waldemar; Hengstler, Jan G.; Hahn, Stephan A.; Siveke, Jens; Rauh, Daniel
    Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer
    In: Cancer Research Jg. 79 (2019) Nr. 9, S. 2367 - 2378
  • Hubner, Richard A.; Cubillo, Antonio; Blanc, Jean-Frédéric; Melisi, Davide; Hoff, Daniel D. von; Wang-Gillam, Andrea; Chen, Li-Tzong; Becker, Claus; Mamlouk, Khalid; Belanger, Bruce; Yang, Yoojung; Jong, Floris A. de; Siveke, Jens T.
    Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin
    In: European Journal of Cancer (EJC) Jg. 106 (2019) S. 24 - 33
  • Vogel, Felix C. E.; Bordag, Natalie; Zügner, E.; Trajkovic-Arsic, Marija; Chauvistré, Heike; Shannan, Batool; Váraljai, Renáta; Horn, Susanne; Magnes, Christoph; Siveke, Jens; Schadendorf, Dirk; Rösch, Alexander
    Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells
    In: Journal of Investigative Dermatology Jg. 139 (2019) Nr. 12, S. 2506 - 2516.e10
  • Wieder, Hinrich; Beer, Ambros J.; Siveke, Jens; Schuster, Tibor; Buck, Andreas K.; Herrmann, Ken; Stollfuss, Jens C.
    18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer
    In: OncoTarget Jg. 9 (2018) Nr. 11, S. 10128 - 10134
  • ter Veer, Emil; van Rijssen, L. Bengt; Besselink, Marc G.; Mali, Rosa M. A.; Berlin, Jordan D.; Boeck, Stefan; Bonnetain, Franck; Chau, Ian; Conroy, Thierry; Van Cutsem, Eric; Deplanque, Gael; Friess, Helmut; Glimelius, Bengt; Goldstein, David; Herrmann, Richard; Labianca, Roberto; Van Laethem, Jean-Luc; Macarulla, Teresa; van der Meer, Jonathan H. M.; Neoptolemos, John P.; Okusaka, Takuji; O'Reilly, Eileen M.; Pelzer, Uwe; Philip, Philip A.; van der Poel, Marcel J.; Reni, Michele; Scheithauer, Werner; Siveke, Jens; Verslype, Chris; Busch, Olivier R.; Wilmink, Johanna W.; van Oijen, Martijn G. H.; van Laarhoven, Hanneke W. M.
    Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease
    In: The Lancet Oncology Jg. 19 (2018) Nr. 3, S. e151 - e160
  • Lee, K.; Bodoky, Gyorgy; Blanc, Jean Frédéric; Siveke, Jens; Macarulla Mercade, T.; Wang-Gillam, Andrew; Chen, L.; Mirakhur, Beloo; Chen, Jie; Jong, Floris A. de
    Decreased appetite (DA) at baseline impacts prognosis in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 5, S. v42 - v43
  • Haas, Michael; Siveke, Jens; Schenk, Michael; Lerch, Markus M.; Caca, Karel; Freiberg-Richter, Jens; Fischer von Weikersthal, Ludwig; Kullmann, Frank; Reinacher-Schick, Anke C.; Fuchs, Martin; Kanzler, Stefan; Kunzmann, Volker; Ettrich, Thomas J.; Krüger, Stephan; Westphalen, Christoph Benedikt; Held, Swantje; Heinemann, Volker; Boeck, Stefan
    Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX : A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’
    In: European Journal of Cancer (EJC) Jg. 94 (2018) S. 95 - 103
  • Marks, David L.; Olson, Rachel L.; Urrutia, Raul; Billadeau, Daniel D.; Roy, Nilotpal; Calin, George A.; Fabbri, Muller; Koutsioumpa, Marina; Iliopoulos, Dimitrios; Ordog, Tamas; Huebert, Robert; Sarmento, Olga; Bamidele, Adebowale O.; Faubion, William; Lomberk, Gwen L.; Siveke, Jens; Ahuja, Nita; Iovanna, Juan; Hlady, Ryan A.; Robertson, Keith; Kisiel, John; Pin, Christopher L.; Fernandez-Zapico, Martin E.
    Epigenetics of gastrointestinal diseases : notes from a workshop
    In: Epigenetics Jg. 13 (2018) Nr. 4, S. 449 - 457
  • Siveke, Jens
    Fibroblast-activating protein : Targeting the roots of the tumor microenvironment
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 9, S. 1412 - 1414
  • Cheung, Phyllis F.; Lutz, Manfred; Siveke, Jens
    Immunotherapy and Combination Strategies in Pancreatic Cancer : Current Status and Emerging Trends
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. 5, S. 286 - 290
  • Chen, Li Tzon; Macarulla, Teresa M.; Blanc, Jean Frédéric; Mirakhur, Beloo; Jong, Floris A. de; Belanger, Bruce; Bekaii-Saab, Tanios; Siveke, Jens
    Impact of dose reduction or dose delay on the efficacy of liposomal irinotecan (nal-IRI)+5-fluorouracil/leucovorin (5-FU/LV) : Survival analysis from NAPOLI-1
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii250 - viii251
  • Macarulla Mercade, Teresa; Bodoky, Gyorgy; Siveke, Jens; Lee, Kyung-hun; Chen, J.; Mirakhur, Beloo; Dean, Andrew; Chen, Li-Tzong; Jong, Floris A. de
    NAPOLI-1 phase III trial outcomes by prior surgery, and disease stage, in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii249 - viii250
  • Cheung, Phyllis F.; Neff, Florian; Neander, Christian; Bazarna, Anna; Savvatakis, Konstantinos; Liffers, Sven-Thorsten; Althoff, Kristina; Lee, Chang-Lung; Moding, Everett J.; Kirsch, David G.; Saur, Dieter; Bazhin, Alexandr V.; Trajkovic-Arsic, Marija; Heikenwalder, Mathias F.; Siveke, Jens
    Notch-induced myeloid reprogramming in spontaneous pancreatic ductal adenocarcinoma by dual genetic targeting
    In: Cancer Research Jg. 78 (2018) Nr. 17, S. 4997 - 5010
  • Urban, Christian; Buck, Achim; Siveke, Jens; Lordick, Florian; Luber, Birgit; Walch, Axel; Aichler, Michaela
    PAXgene fixation enables comprehensive metabolomic and proteomic analyses of tissue specimens by MALDI MSI
    In: Biochimica et Biophysica Acta (BBA) - General Subjects Jg. 1862 (2018) Nr. 1, S. 51 - 60
  • Vogel, Arndt; Kasper, Stefan; Bitzer, Michael; Block, Andreas; Sinn, Marianne; Schulze-Bergkamen, Henning; Moehler, Markus; Pfarr, Nicole; Endris, Volker; Goeppert, Benjamin; Merx, Kirsten; Schnoy, Elisabeth; Siveke, Jens; Michl, Patrick; Waldschmidt, Dirk; Kuhlmann, Jan; Geissler, Michael; Kahl, Christoph; Evenkamp, Ralf; Schmidt, Torben; Kuhlmann, Alexander; Weichert, Wilko; Kubicka, Stefan
    PICCA study : panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study
    In: European Journal of Cancer (EJC) Jg. 92 (2018) S. 11 - 19
  • Lakatos, Gábor; Lee, K.; Siveke, Jens; Blanc, Jean Frédéric; Macarulla Mercadé, Teresa; Dean, Andrew; Bodoky, Gyorgy; Mirakhur, Beloo; Chen, Jie; Wang-Gillam, Andrea; Chen, Li Li; Jong, Floris A. de
    Prognostic value of baseline biliary stents on outcomes in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the NAPOLI-1 trial
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 5, S. v42
  • Chen, Li-Tzong; Siveke, Jens; Wang-Gillam, Andrea; Li, Chung-Pin; Bodoky, György; Dean, Andrew P.; Shan, Yan-Shen; Jameson, Gayle S.; Macarulla, Teresa; Lee, Kyung-Hun; Cunningham, David; Blanc, Jean-Frédéric; Chiu, Chang-Fang; Schwartsmann, Gilberto; Braiteh, Fadi S.; Mamlouk, Khalid; Belanger, Bruce; de Jong, Floris A.; Hubner, Richard A.
    Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1 : Expanded analysis of a global phase 3 trial
    In: European Journal of Cancer (EJC) Jg. 105 (2018) S. 71 - 78
  • Macurulla Mercade, Teresa; Wang-Gillam, Andrea; Chen, L.; Blanc, Jean Frédéric; Lee, K.; Bodoky, Gyorgy; Dean, Andrew; Chen, Jie; Mirakhur, Beloo; Siveke, Jens; de Jong, Floris A.
    The effect of best response to prior anticancer therapy on efficacy outcomes in the NAPOLI-1 trial of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 5, S. v42
  • Trajkovic-Arsic, M.; Heid, I.; Steiger, K.; Gupta, A.; Fingerle, A.; Wörner, C.; Teichmann, N.; Sengkwawoh-Lueong, S.; Wenzel, P.; Beer, A.J.; Esposito, I.; Braren, R.; Siveke, Jens
    Apparent Diffusion Coefficient (ADC) predicts therapy response in pancreatic ductal adenocarcinoma
    In: Scientific Reports Jg. 7 (2017) 10.1038/s41598-017-16826-z
  • Frohling, S.; Barth, T. F.; Groschel, S.; Folprecht, G.; Richter, S.; Mayer-Steinacker, R.; Schultheiss, M.; Moller, P.; Bauer, S.; Siveke, Jens; Dettmer, S.; Richter, D.; Heining, C.; Horak, P.; Glimm, H.; Jager, D.; Von Kalle, C.; Schlenk, R.
    CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601)
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5, -
  • Heid, Irina; Steiger, Katja; Trajkovic-Arsic, Marija; Settles, Marcus; Eßwein, Manuela R.; Erkan, Mert; Kleeff, Jörg; Jäger, Carsten; Friess, Helmut; Haller, Bernhard; Steingötter, Andreas; Schmid, Roland M.; Schwaiger, Markus; Rummeny, Ernst J.; Esposito, Irene; Siveke, Jens; Braren, Rickmer F.
    Co-clinical assessment of tumor cellularity in pancreatic cancer
    In: Clinical Cancer Research Jg. 23 (2017) Nr. 6, S. 1461 - 1470
  • Chen, Nai-Ming; Neesse, Albrecht; Dyck, Moritz Lino; Steuber, Benjamin; Koenig, Alexander O.; Lubeseder-Martellato, Clara; Winter, Thore; Forster, Teresa; Bohnenberger, Hanibal; Kitz, Julia; Reuter-Jessen, Kirsten; Griesmann, Heidi; Gaedcke, Jochen; Grade, Marian; Zhang, Jin-San; Tsai, Wan-Chi; Siveke, Jens; Schildhaus, Hans-Ulrich; Ströbel, Philipp; Johnsen, Steven A.; Ellenrieder, Volker; Hessmann, Elisabeth
    Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity
    In: Gastroenterology Jg. 152 (2017) Nr. 6, S. 1507 - 1520.e15
  • Hessmann, Elisabeth; Johnsen, Steven A; Siveke, Jens; Ellenrieder, Volker
    Epigenetic treatment of pancreatic cancer : Is there a therapeutic perspective on the horizon?
    In: Gut Jg. 66 (2017) Nr. 1, S. 168 - 179
  • Haas, Michael; Ormanns, Steffen; Baechmann, Sibylle; Remold, Anna; Kruger, Stephan; Westphalen, Christoph B.; Siveke, Jens; Wenzel, Patrick; Schlitter, Anna Melissa; Esposito, Irene; Quietzsch, Detlef; Clemens, Michael R.; Kettner, Erika; Laubender, Ruediger P.; Jung, Andreas; Kirchner, Thomas; Boeck, Stefan; Heinemann, Volker
    Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
    In: British Journal of Cancer (BJC) Jg. 116 (2017) Nr. 11, S. 1462 - 1469
  • Mishra, Vivek Kumar; Wegwitz, Florian; Kosinsky, Robyn Laura; Sen, Madhobi; Baumgartner, Roland; Wulff, Tanja; Siveke, Jens; Schildhaus, Hans-Ulrich; Najafova, Zeynab; Kari, Vijayalakshmi; Kohlhof, Hella; Hessmann, Elisabeth; Johnsen, Steven A.
    Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4-and MYC-dependent manner
    In: Nucleic Acids Research Jg. 45 (2017) Nr. 11, S. 6334 - 6349
  • Schmohl, Kathrin A.; Gupta, Aayush; Grünwald, Geoffrey K.; Trajkovic-Arsic, Marija; Klutz, Kathrin; Braren, Rickmer; Schwaiger, Markus; Nelson, Peter J.; Ogris, Manfred; Wagner, Ernst; Siveke, Jens; Spitzweg, Christine
    Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene
    In: OncoTarget Jg. 8 (2017) Nr. 20, S. 33393 - 33404
  • Ma, Xiaopeng; Phi Van, Valerie; Kimm, Melanie A.; Prakash, Jaya; Kessler, Horst; Kosanke, Katja; Feuchtinger, Annette; Aichler, Michaela; Gupta, Aayush; Rummeny, Ernst J.; Eisenblätter, Michel; Siveke, Jens; Walch, Axel K.; Braren, Rickmer; Ntziachristos, Vasilis; Wildgruber, Moritz
    Integrin-Targeted Hybrid Fluorescence Molecular Tomography/X-ray Computed Tomography for Imaging Tumor Progression and Early Response in Non-Small Cell Lung Cancer
    In: Neoplasia: An International Journal for Oncology Research Jg. 19 (2017) Nr. 1, S. 8 - 16
  • Bäcker, Veronika; Cheung, Fung-Yi; Siveke, Jens; Fandrey, Joachim; Winning, Sandra
    Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis
    In: PLoS ONE Jg. 12 (2017) Nr. 12, S. e0190074
  • Lubeseder-Martellato, Clara; Alexandrow, Katharina; Hidalgo-Sastre, Ana; Heid, Irina; Boos, Sophie Luise; Briel, Thomas; Schmid, Roland M.; Siveke, Jens
    Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic Lesions
    In: EBioMedicine Jg. 15 (2017) S. 90 - 99
  • Hubner, R. A.; Chen, L. T.; Li, C. P.; Bodoky, G.; Dean, A.; Lee, K. H.; Cunningham, D.; Siveke, Jens; Braiteh, F. S.; de Jong, F. A.; Belanger, B.; Walls, R.; Mody, P. D.; von Hoff, D. D.; Wang-Gillam, A.
    Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma (mPDAC) patients treated with liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alon
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Pelzer, Uwe; Blanc, Jean-Frédéric; Melisi, Davide; Cubillo, Antonio; Von Hoff, Daniel D.; Wang-Gillam, Andrea; Chen, Li-Tzong; Siveke, Jens; Wan, Yin; Solem, Caitlyn T.; Botteman, Marc F.; Yang, Yoojung; De Jong, Floris A.; Hubner, Richard A.
    Quality-adjusted survival with combination nal-IRIFU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy : a Q-TWiST analysis
    In: British Journal of Cancer (BJC) Jg. 116 (2017) Nr. 10, S. 1247 - 1253
  • Chen, L-T.; Dean, A.; Macarulla, T.; Belanger, B.; Cunningham, D.; Li, C-P.; Hubner, R.; Jameson, G.S.; Siveke, Jens; Wang-Gillam, A.; Lee, K-H.; von Hoff, D.D.; Bodoky, G.; Chiu, C-F.; Bayever, E.; Blanc, J-F.; Schwartsmann, G.; de Jong, F.; Shan, Y-S.; Braiteh, F.
    Final results of NAPOLI-1 : A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 622PD
  • Heid, I.; Trajkovic-Arsic, M.; Steiger, K.; Settles, M.; Steingotter, A.; Gupta, A.; Lubeseder-Martellato, C.; Schmid, R. M.; Rummeny, E.; Siveke, Jens; Braren, R.
    Gemcitabine impairs tumor perfusion in stroma rich murine endogenous PDAC
    In: European Journal of Cancer (EJC) Jg. 69 (2016) Nr. Suppl. 1, S. S67 - S68
  • Hidalgo-Sastre, Ana; Brodylo, Roxanne L; Lubeseder-Martellato, Clara; Sipos, Bence; Steiger, Katja; Lee, Marcel; von Figura, Guido; Grünwald, Barbara; Zhong, Suyang; Trajkovic-Arsic, Marija; Neff, Florian; Schmid, Roland M; Siveke, Jens
    Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model
    In: The American Journal of Pathology Jg. 186 (2016) Nr. 11, S. 2934 - 2944
  • Trajkovic-Arsic, M.; Kalideris, E.; Sun, N.; Feuchtinger, A.; Gupta, A.; Aichler, M.; Schmid, R. M.; Walch, A.; Siveke, Jens
    Identification of metabolic changes in Pancreatic Ductal Adenocarcinoma
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 76 - 77
  • Diersch, S; Wirth, M; Schneeweis, C; Jörs, S; Geisler, F; Siveke, Jens; Rad, R; Schmid, R M; Saur, D; Rustgi, A K; Reichert, M; Schneider, G
    Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells
    In: Oncogene Jg. 35 (2016) Nr. 29, S. 3880 - 3886
  • Lubeseder-Martellato, Clara; Hidalgo-Sastre, Ana; Hartmann, Carolin; Alexandrow, Katharina; Kamyabi-Moghaddam, Zahra; Sipos, Bence; Wirth, Matthias; Neff, Florian; Reichert, Maximilian; Heid, Irina; Schneider, Günter; Braren, Rickmer; Schmid, Roland M; Siveke, Jens
    Membranous CD24 drives the epithelial phenotype of pancreatic cancer
    In: OncoTarget Jg. 7 (2016) Nr. 31, S. 49156 - 49168
  • Grüner, Barbara M.; Winkelmann, Isabel; Feuchtinger, Annette; Sun, Na; Balluff, Benjamin; Teichmann, Nicole; Herner, Alexander; Kalideris, Evdokia; Steiger, Katja; Braren, Rickmer; Aichler, Michaela; Esposito, Irene; Schmid, Roland M.; Walch, Axel; Siveke, Jens
    Modeling therapy response and spatial tissue distribution of erlotinib in pancreatic cancer
    In: Molecular Cancer Therapeutics Jg. 15 (2016) Nr. 5, S. 1145 - 1152
  • Braren, Rickmer F; Siveke, Jens
    Next-generation metabolic imaging in pancreatic cancer
    In: Gut Jg. 65 (2016) Nr. 3, S. 367 - 369
  • Heid, I.; Lubeseder-Martellato, C.; Trajkovic-Arsic, M.; Rummeny, E.; Steiger, K.; Schmid, R. M.; Braren, R.; Siveke, Jens
    RAC1 activity is necessary for the development of murine undifferentiated PDAC
    In: European Journal of Cancer (EJC) Jg. 69 (2016) Nr. Suppl. 1, S. 140
  • Bitzer, Michael; Horger, Marius; Giannini, Edoardo G; Ganten, Tom M; Wörns, Marcus A; Siveke, Jens; Dollinger, Matthias M; Gerken, Guido; Scheulen, Max Ernst; Wege, Henning; Zagonel, Vittorina; Cillo, Umberto; Trevisani, Franco; Santoro, Armando; Montesarchio, Vincenzo; Malek, Nisar P; Holzapfel, Julia; Herz, Thomas; Ammendola, Astrid S; Pegoraro, Stefano; Hauns, Bernhard; Mais, Anna; Lauer, Ulrich M; Henning, Stefan W; Hentsch, Bernd
    Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study
    In: Journal of Hepatology Jg. 65 (2016) Nr. 2, S. 280 - 288
  • Wang-Gillam, A.; Belanger, B.; Jameson, G.S.; Li, C-P.; Mamlouk, K.; Cunningham, D.; Bodoky, G.; de Jong, F.; Hubner, R.A.; von Hoff, D.D.; Chiu, C-F.; Blanc, J-F.; Shan, Y-S.; Dean, A.; Lee, K-H.; Chen, L-T.; Schwartsmann, G.; Macarulla, T.; Braiteh, F.; Siveke, Jens
    Time course of selected treatment emergent adverse events (TEAEs) in NAPOLI-1 : A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 693P
  • Dorneburg, Carmen; Goß, Annika V; Fischer, Matthias; Roels, Frederik; Barth, Thomas F E; Berthold, Frank; Kappler, Roland; Oswald, Franz; Siveke, Jens; Molenaar, Jan J; Debatin, Klaus-Michael; Beltinger, Christian
    γ-Secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets
    In: OncoTarget Jg. 7 (2016) Nr. 39, S. 62799 - 62813
  • Ormanns, Steffen; Siveke, Jens; Heinemann, Volker; Haas, Michael L.; Sipos, Bence; Schlitter, Anna Melissa Elissa; Esposito, Iréne; Jung, Andreas; Laubender, Rüdiger Paul Aul; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael Roland; Gauler, Thomas; Märten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas; Boeck, Stefan
    PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer : a translational subgroup analysis from AIO-PK0104
    In: BMC Cancer Jg. 14 (2014) Nr. 1, S. 624
  • Boeck, S. H.; Ormanns, S.; Laubender, R. P.; Jung, A.; Siveke, Jens; Haas, M.; Neumann, J.; Vehling-Kaiser, U.; Winkelmann, C.; von Weikersthal, L. F.; Clemens, M. R.; Gauler, Thomas; Marten, A.; Klein, S.; Kojouharoff, G.; Geissler, M.; Greten, T. F.; Kirchner, T.; Heinemann, V.
    Phosphorylated ERK (pERK) as biomarker in patients with advanced pancreatic cancer treated with erlotinib within a randomized phase III trial (AIO-PK0104)
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 4 Suppl., S. 189
  • Bitzer, M.; Ganten, T. M.; Woerns, M. A.; Siveke, Jens; Dollinger, M. M.; Scheulen, Max Ernst; Wege, H.; Giannini, E. G.; Cillo, U.; Trevisani, F.; Santoro, A.; Montesarchio, V.; Mais, A.; Hauns, B.; Asche, J.; Herz, T.; Pegoraro, S.; Ammendola, A.; Henning, S. W.; Hentsch, B.; SHELTER Study Grp
    Resminostat in advanced hepatocellular carcinoma (HCC) : Overall survival subgroup analysis of prognostic factors in the SHELTER trial
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. e15088
  • Seufferlein, Thomas; Porzner, Marc; Becker, Thomas; Budach, Volker G.F.; Ceyhan, Güralp Onur; Esposito, Iréne; Fietkau, Rainer; Follmann, Markus; Friess, Helmut M.; Galle, Peter Robert; Geiler, M.; Glanemann, Matthias; Gress, Thomas Matthias; Heinemann, Volker; Hohenberger, Werner Max; Hopt, Ulrich Theodor; Izbicki, Jakob Robert; Klar, Ernst A.; Kleeff, J. H.; Kopp, Ina B.; Kullmann, Frank; Langer, T.; Langrehr, Jan Michael; Lerch, Markus M.; Löhr, Matthias J.; Lüttges, Jutta Elisabeth; Lutz, Manfred Paul; Mayerle, Julia V.; Michl, Patrick; Möller, Peter; Molls, Michael M.; Münter, Marc W.; Nothacker, Monika J.; Oettle, Helmut; Post, Stefan; Reinacher-Schick, Anke C.; Röcken, Christoph; Roeb, Elke; Saeger, Hans Detlev; Schmid, Roland Michael; Schmiegel, Wolff Helmut; Schoenberg, Michael H.; Siveke, Jens; Stuschke, Martin; Tannapfel, Andrea; Uhl, Waldemar H.; Unverzagt, Susanne; Van Oorschot, B.; Vashist, Yogesh Kumar; Werner, Jens; Yekebaş, Emre F.
    S3-Leitlinie zum exokrinen Pankreaskarzinom
    In: Zeitschrift für Gastroenterologie Jg. 51 (2013) Nr. 12, S. 1395 - 1440
  • Ardito, Christine M.; Grüner, Barbara M.; Takeuchi, Kenneth K.; Lubeseder-Martellato, Clara; Teichmann, Nicole; Mazur, Pawel K.; DelGiorno, Kathleen E.; Carpenter, Eileen S.; Halbrook, Christopher J.; Hall, Jason C.; Pal, Debjani; Briel, Thomas; Herner, Alexander; Trajkovic-Arsic, Marija; Sipos, Bence; Liou, Geou-Yarh; Storz, Peter; Murray, Nicole R.; Threadgill, David W.; Sibilia, Maria; Washington, M. Kay; Wilson, Carole L.; Schmid, Roland M.; Raines, Elaine W.; Crawford, Howard C.; Siveke, Jens
    EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
    In: Cancer Cell Jg. 22 (2012) Nr. 3, S. 304 - 317
  • Grüner, Barbara M.; Hahne, Hannes; Mazur, Pawel K.; Trajkovic-Arsic, Marija; Maier, Stefan; Esposito, Irene; Kalideris, Evdokia; Michalski, Christoph W.; Kleeff, Jörg; Rauser, Sandra; Schmid, Roland M.; Küster, Bernhard; Walch, Axel; Siveke, Jens
    MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer
    In: PLoS ONE Jg. 7 (2012) Nr. 6, S. e39424
  • Falkowska-Hansen, Berit; Kollar, Jasmin; Grüner, Barbara M.; Schanz, Merle; Boukamp, Petra; Siveke, Jens; Rethwilm, Axel; Kirschner, Marc
    An inducible Tet-Off-H2B-GFP lentiviral reporter vector for detection and in vivo isolation of label-retaining cells
    In: Experimental Cell Research Jg. 316 (2010) Nr. 11, S. 1885 - 1895
  • Mazur, Pawel K.; Grüner, Barbara M.; Nakhai, Hassan; Sipos, Bence; Zimber-Strobl, Ursula; Strobl, Lothar J.; Radtke, Freddy; Schmid, Roland M.; Siveke, Jens
    Identification of epidermal pdx1 expression discloses different roles of notch1 and notch2 in murine krasG¹²D-induced skin carcinogenesis in vivo
    In: PLoS ONE Jg. 5 (2010) Nr. 10, S. e13578
  • Mazur, Pawel K.; Einwächter, Henrik; Lee, Marcel; Sipos, Bence; Nakhai, Hassan; Rad, Roland; Zimber-Strobl, Ursula; Strobl, Lothar J.; Radtke, Freddy; Klöppel, Günter; Schmid, Roland M.; Siveke, Jens
    Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma
    In: Proceedings of the National Academy of Sciences of the United States of America Jg. 107 (2010) Nr. 30, S. 13438 - 13443
  • Vorworte / Nachworte

  • Real, F. X.; Siveke, Jens
    Pancreatic cancer transcriptomes : molecular stratification in the adjuvant setting
    In: Annals of Oncology Jg. 32 (2021) Nr. 2, S. 133 - 135
  • Abstracts

  • Lanzafame, Helena; Hamacher, Rainer; Mavroeidi, Ilektra-Antonia; Pabst, Kim; Hirmas, Nader; Kessler, Lukas; Bartel, Timo; Leyser, Stephan; Barbato, Francesco; Schuler, Martin; Bauer, Sebastian; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang;
    68Ga-FAPI PET/CT novel diagnostic tool in sarcoma
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S415
  • Bartel, Timo; Fendler, Wolfgang; Pabst, Kim; Hirmas, Nader; Umutlu, Lale; Grafe, Hong; Praus, Christine; Nader, Michael; Podleska, Lars; Barbato, Francesco; Siveke, Jens; Herrmann, Ken; Grünwald, Viktor; Hamacher, Rainer
    68Ga-FAPI-46 PET for imaging of FAP expressing cancer - interim findings from a single-center prospective interventional single-arm clinical trial
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P706
  • Mavroeidi, I.; Reissig, T.; Kalbourtzis, S.; Liffers, S-T.; Herold, T.; Kasper-Virchow, S.; Schildhaus, Hans-Ulrich; Schuler, Martin H. H.; Siveke, Jens;
    DNA damage repair pathways in biliary tract cancer : A new target for precision medicine?
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S223
  • Pabst, Kim; Hamacher, Rainer; Schaarschmidt, Benedikt; Kessler, Lukas; Cheung, Phyllis; Liffers, Sven-Thorsten; Miera, Monika; Kostbade, Karina; Lanzafame, Helena; Mavroeidi, Ilektra; Hirmas, Nader; Costa, Pedro Fragoso; Nader, Michael; Bartel, Timo; Schuler, Martin; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens; Schildhaus, Hans-Ulrich; Fendler, Wolfgang
    Fibroblast activation protein alpha (FAPα) directed imaging and radioligand therapy in patients with solitary fibrous tumor (SFT)
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P714
  • Watanabe, Masao; Grafe, Hong; Hirmas, N.; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim; Nader, Michael; Siveke, Jens; Fendler, Wolfgang; Herrmann, Ken; Weber, Manuel;
    Head-to-head comparison of68Ga-FAPI46 PET/CT,18F-FDG PET/CT, and contrast- enhanced CT in patient with various solid tumors
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. 166 - S167
  • Mavroeidi, I. A.; Reissig, T.; Kalbourtzis, S.; Liffers, S.-T.; Herold, T.; Treckmann, Jürgen-Walter; Schildhaus, Hans-Ulrich; Schuler, Martin; Siveke, Jens T.;
    Molecular characterization of biliary tract cancer at a single comprehensive cancer center focusing on DNA damage repair genes
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 62
  • Pabst, Kim; Hamacher, Rainer; Lanzafame, Helena; Mavroeidi, Ilektra-Antonia; Bartel, Timo; Nader, Michael; Bauer, Sebastian; Siveke, Jens; Weber, Manuel; Kersting, David; Jentzen, Walter; Ahrens, M.; Herrmann, Ken; Fragoso Costa, Pedro;
    Occurence of hematotoxic side effects during 90Y-FAPI-46 radioligand therapy (RLT) in patients with advanced metastatic tumor diseases
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S671
  • Dorman, K.; Heinemann, V.; Snijder, R. J.; Waldschmidt, D. T.; Freiberg-Richter, J.; Siveke, Jens T.; Fischer von Weikersthal, L.; Reinacher-Schick, A.; Schenk, M.; Mayerle, J.; Caca, K.; Stahl, Michael; Kullmann, F.; Zhang, D.; Held, S.; Abdul-Ahad, A.; von Bergwelt-Baildon, M.; Boeck, S.; Haas, M.;
    Analyse zweier prospektiver klinischer Studien der Arbeitsgemeinschaft Internistische Onkologie mit der “Burden of Therapy” (BOTh®TM) Methode : einem neuen Instrument zur Evaluation unerwünschter Ereignisse beim metastasierten Pankreaskarzinom
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 295
  • Albrecht, L. J.; Höwner, A.; Griewank, Klaus; Lueong, S. S.; von Neuhoff, N.; Horn, Peter A.; Sucker, A.; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, S.; Siveke, Jens T.; Schadendorf, Dirk; Váraljai, R.; Rösch, Alexander;
    Im Plasma zirkulierende zellfreie mRNA ermöglicht die minimal-invasive und Genotyp-unabhängige Therapieüberwachung bei Patienten mit Melanom
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 12 - 13
  • Sivakumar, S.; Macarulla, T.; Grell, P.; Chee, C.; Krishnamurthy, A.; Ka Wong, M.; Michael, M.; Milella, M.; Prager, G.; Springfeld, C.; Collignon, J.; Siveke, Jens; Santoro, A.; Lin, C.; Peltola, K.; Bostel, G.; Jankovic, D.; Altzerinakou, M.; Fabre, C.; Bai, L.
    P-5 Phase II study (daNIS-1) of the anti-TGF-β monoclonal antibody (mAb) NIS793 +/- spartalizumab in combination with nab-paclitaxel/gemcitabine (NG) versus NG alone in patients with first-line metastatic pancreatic ductal adenocarcinoma (mPDAC)
    In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 4, S. 247
  • Heilig, C.E.; Teleanu, M-V.; Bhatti, I.A.; Richter, S.; Siveke, Jens; Wagner, S.; Kopp, H-G.; Kindler, T.; Illert, L.; Golf, A.; Dormann, K.; Benner, A.; Süsse, H.; Freitag, A.; Von Kalle, C.; Glimm, H.; Hübschmann, D.; Fröhling, S.; Schlenk, R.F.;
    Randomized phase II study of trabectedin/olaparib compared to physician’s choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies
    Annual Meeting of the European-Society-for-Medical-Oncology (ESMO): SEP 09-13, 2022; Paris, France,
    In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S762 - S763
  • Hamacher, R.W.; Pabst, K.M.; Kessler, Lukas; Costa, Pedro Fragoso; Ferdinandus, J.; Weber, Manuel; Lippert, M.; Lückerath, Katharina; Hirmas, N.; Kostbade, K.; Mavroeidi, I.A.; Schuler, Martin H. H.; Ahrens, M.; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens T.; Fendler, Wolfgang P.;
    Safety and efficacy of [90Y]Y-FAPI-46 radioligand therapy in patients with advanced sarcomas and other cancer entities
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1231 - S1232
  • Tiwary, K.; Mader, S.; Hauff, S.; Valar, A.; Ditrich, T.; Zhang, X.; Kleger, A.; Seufferlein, T.; Sanz, B.; Siveke, Jens; Walter, K.; Hermann, P.C.
    Selective elimination of CD133+ cancer stem cells using novel BET/HDAC inhibitor TW09 as therapy for pancreatic ductal adenocarcinoma (PDAC)
    In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 8, S. 1411
  • Pabst, K. M.; Trajkovic-Arsic, M.; Cheung, P. F.; Kessler, Lukas; Hirmas, N.; Nader, M.; Bartel, T.; Schaarschmidt, B. M.; Kasper, Stefan; Siveke, Jens T.; Hamacher, R.; Schmidt, H. H. J.; Ingenwerth, M.; Herrmann, Ken; Fendler, Wolfgang P.;
    Superiority of [68Ga]Ga-FAPI-46 over [18F]F-FDG PET/CT for cholangiocarcinoma imaging
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S192 - S193
  • Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Gruenwald, V.; von Tresckow, Bastian; Hanoun, C.; Aigner, Clemens; Glas, M.; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.;
    Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S119 - S120
  • Kessler, Lukas; Ferdinandus, J.; Costa, P. F.; Weber, Manuel; Hirmas, N.; Kostbade, K.; Bauer, Sebastian; Dirksen, U.; Zarrad, F.; Nader, M.; Grafe, Hong; Chodyla, M.; Milosevic, A.; Umutlu, Lale; Schuler, Martin; Ahrens, M.; Podleska, Lars E.; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.; Hamacher, R.;
    A novel theranostic approach for sarcoma : Insights on diagnostic and therapeutic use of FAP-radioligands
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 11 - 12
  • Salama, A.K.S.; Cheshuk, V.; Siveke, Jens; Berrocal, A.; Abdullah, S.E.; Lockwood, S.; McCully, M.L.; Kee, D.
    Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in previously untreated patients with metastatic uveal melanoma
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 855
  • Kessler, Lukas; Hamacher, Rainer; Ferdinandus, Justin; Zarrad, Fadi; Hirmas, Nader; Schildhaus, Hans-Ulrich; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Ga-68-FAPI for sarcoma imaging : Data from the FAPI-PET prospective observational trial
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. Suppl. 1, 126
  • Ferdinandus, J.; Costa Fragoso, P.; Kessler, Lukas; Weber, Manuel; Hirmas, N.; Kostbade, K.; Bauer, Sebastian; Schuler, Martin; Ahrens, M.; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang; Hamacher, R.
    Initial clinical experience with [Y-90]Y-FAPI-46 radioligand therapy for advanced stage solid tumors
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290
  • Hartlapp, I.; Valta-Seufzer, D.; Siveke, Jens; Algül, H.; Goekkurt, E.; Siegler, G.M.; Martens, U.M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T.J.; Held, S.; Keller, R.; Anger, F.; Germer, C-T.; Stang, H.A.; Heinemann, V.; Kunzmann, V.
    Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multi-agent induction chemotherapy : Results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 1091
  • Kasper, Stefan; Goetze, Thorsten Oliver; Stintzing, Sebastian; Hofheinz, Ralf Dieter; Sinn, Marianne; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Keitel, Verena; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Kolov, Alexander; Edelmann, Thomas; Stein, Alexander; Trarbach, Tanja; Junge, Sabine; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    RAMucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic colorectal cancer : Safety results from the phase IIb part of the RAMTAS phase II/III trial of the German AIO (AIO-KRK-0316)
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 3566 - 3566
  • Siveke, Jens; Bauer, Sebastian; German Cancer Consortium (DKTK);
    Comprehensive genomic analysis of rare cancers : Results of the MASTER precision oncology trial of the German Cancer Consortium
    AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,
    In: Cancer Research Jg. 80 (2020) Nr. Suppl. 16, S. 821
  • Behrens, Diana; Lawlor, Rita T.; Heeschen, Christopher; Buettner, B.; Siveke, Jens; Hoffmann, Jens
    Correlation of molecular profiles with response to targeted drugs in pancreatic cancer models
    In: European Journal of Cancer (EJC) Jg. 138, Supplement 2 (2020) S. S58 - S59
  • Patnana, Pradeep Kumar; Behrens, M.; Klotz, L.; Liebmann, M.; Frank, D.; Nimmagadda, C.; Siveke, Jens; Trajkovic-Arsic, Marija; Hanenberg, Helmut; Thivakaran, Aniththa; Khandanpour, Cyrus;
    Growth factor independence 1 expression induced metabolic vulnerabilities and presents novel therapeutic opportunities in acute myeloid leukemia
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 43 - 44
  • Kasper, Stefan; Hofheinz, R.D.; Stintzing, S.; Götze, T.O.; Sinn, M.; Dechow, T.; Ettrich, T.J.; Keitel, V.; Graeven, U.; Fischer von Weikersthal, L.; Kolov, A.; Edelmann, T.; Stein, A.; Trarbach, T.; Junge, S.; Pauligk, C.; Virchow, I.; Siveke, Jens; Al-Batran, S-E.; Schuler, Martin
    Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer : The RAMTAS trial of the German AIO
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S427 - S428
  • Kasper, Stefan; zur Hausen, Gerrit; Stein, Alexander; Stintzing, Sebastian; Berger, Andreas; Loges, Sonja; Hofheinz, Ralf; Trarbach, Tanja; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Goetze, Thorsten Oliver; Hagen, Volker A.; Burock, Susen; Hoffmeister, Albrecht; Dechow, Tobias Nicolaas; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients : The RAMTAS trial of the German AIO (KRK-0316)
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. TPS3617 - TPS3617
  • Johansson, Patricia; Dierichs, L.; Klein-Hitpaß, Ludger; Bergmann, A.; Menninger, S.; Habenberger, P.; Klebl, B.; Siveke, Jens; Dührsen, U.; Choidas, A.; Dürig, Jan;
    Anti-leukemic activity through CDK9 inhibition in T-cell prolymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 218
  • Horak, Peter; Heining, Christoph; Kreutzfeldt, Simon; Heilig, Christoph E.; Möhrmann, Lino; Gieldon, Laura; Fröhlich, Martina; Uhrig, Sebastian; Hübschmann, Daniel; Beck, Katja; Richter, Daniela; Wolf, Stephan; Pfütze, Katrin; Geörg, Christina; Meißburger, Bettina; Klauschen, Frederick; Ochsenreither, Sebastian; Folprecht, Gunnar; Siveke, Jens; Bauer, Sebastian; Kindler, Thomas; Brandts, Christian; Börries, Melanie; Bubnoff, Nikolas von; Spiekermann, Karsten; Jost, Philipp J.; Schulze-Osthoff, Klaus; Bitzer, Michael; Schirmacher, Peter; Kalle, Christof von; Schlenk, Richard; Klink, Barbara; Hutter, Barbara; Weichert, Wilko; Stenzinger, Albrecht; Schröck, Evelin; Brors, Benedikt; Glimm, Hanno; Fröhling, Stefan
    Clinical relevance of comprehensive genomic analysis in advanced-stage cancers and rare malignancies : Results from the MASTER trial of the German Cancer Consortium
    In: Cancer Research Jg. 79 (2019) Nr. Suppl. 13,
  • Lorenzen, Sylvie; Quante, Michael; Rauscher, Isabel; Slotta-Huspenina, Julia; Becker, Karl Friedrich; Weichert, Wilko; Feith, Marcus; Friess, Helmut; Combs, Stephanie E.; Weber, Wolfgang; Haller, Bernhard; Angele, Martin K.; Albertsmeier, Markus; Blankenstein, Christiane; Kasper, Stefan; Zimmermann, Jens Peter; Algül, Hana; Schmid, Roland M.; Schwaiger, Markus; Siveke, Jens
    PET-directed combined modality therapy for gastroesophageal junction cancer : First results of the prospective MEMORI trial
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 4018 - 4018
  • Dantes, Z.; Hennig, A.; Wirth, M.; Feldmann, K.; Engleitner, T.; Lange, S.; Öllinger, R.; Muckenhuber, A.; Yen, H.-Y.; Steiger, K.; Dantes, M.; Strobel, O.; Braren, Rickmer; Welsch, T.; Martignoni, M.; Ceyhan, G. O.; Weichert, W.; Rustgi, A.; Siveke, Jens; Stange, Daniel; Schmid, R. M.; Rad, R.; Schneider, G.; Reichert, M.;
    Advanced organoid culture technology in pancreatic cancer and its translational applications
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 206
  • Schlenk, Richard; Barth, T.; Gröschel, S.; Heilig, C.; Folprecht, Gunnar; Richter, S.; Mayer-Steinacker, R.; Markus, S.; Möller, P.; Bauer, Sebastian; Siveke, Jens; Dettmer, S.; Richter, D.; Heining, C.; Horak, P.; Jäger, D.; Glimm, H.; Kalle, Christof von; Fröhling, S.;
    CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT-PMO-1601)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 156
  • Smeets, E.M.M.; Feuerecker, B.; Teuwen, J.; van der Laak, J.; Gotthardt, M.; Siveke, Jens; Braren, R.; Ciompi, F.; Aarntzen, E.
    Metabolic heterogeneity as a PET-biomarker predicts overall survival of pancreatic cancer patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 97
  • Behrens, Diana; Büttner, Britta; Lawlor, Rita L.; Heeschen, Christopher; Buchholz, Malte; Siveke, Jens; Wengner, Antje M.; Saluja, Ashok; Hoffmann, Jens
    Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer
    In: Cancer Research Jg. 78 (2018) Nr. Suppl. 13,
  • Behrens, D.; Lawlor, R. T.; Heeschen, C.; Buchholz, M.; Siveke, Jens; Wengner, A.; Saluja, A.; Buettner, B.; Hoffmann, J.;
    Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer
    30th EORTC – NCI – AACR Symposium; 13 Nov - 16 Nov 2018; Dublin, Ireland,
    In: European Journal of Cancer (EJC) Jg. 103 (2018) Nr. Supplement 1, S. E101
  • Macarulla Mercadé, Teresa; Wang-Gillam, Andrea; Chen, L.; Blanc, Jean Frédéric; Lee, K.; Bodoky, Gyorgy; Dean, Andrew; Siveke, Jens; Mirakhur, Beloo; Chen, J.; de Jong, F.
    Prognostic effect of primary tumor location in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 5, S. v41 - v42
  • Kunzmann, Volker; Martens, Uwe Marc; Alguel, Hana; Siveke, Jens; Goekkurt, Eray; Pelzer, Uwe; Siegler, Gabriele Margareta; Hennes, Elke; Waldschmidt, Dirk; Jakobs, Ralf; Ferenczy, Peter; Keller, Ralph; Boeck, Stefan Hubert; Kullmann, Frank; Kapp, Markus; Germer, Christoph Thomas
    Secondary resectability in locally advanced pancreatic cancer (LAPC) after nab-paclitaxel/gemcitabine- versus FOLFIRINOX-based induction chemotherapy : Interim results of a randomized phase II AIO trial (NEOLAP)
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 4_suppl, S. 348 - 348
  • Macarulla, T. M.; Hubner, R.; Blanc, J. F.; Wang-Gillam, A.; Li, C. P.; Bodoky, G.; Dean, A. P.; Yanshen, S.; Jameson, G. S.; Lee, K. H.; Chiu, C. F.; Schwartsmann, G.; Braiteh, F. S.; Cunningham, D.; Chen, L. T.; Von Hoff, D. D.; Mamlouk, K. K.; de Jong, F. A.; Siveke, Jens
    Subgroup analysis by baseline (BL) weight-associated parameters : A phase III study of liposomal irinotecan (nal-IRI)+/--5fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with g
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 4, S. 410
  • Macarulla, T. M.; Siveke, Jens; Dean, A. P.; Hubner, R.; Blanc, J. F.; Cunningham, D.; Chen, L. T.; Mirakhur, B.; Chen, J.; de Jong, F. A.; Wang-Gillam, A.
    Subgroup analysis by baseline pain intensity (BPI) and analgesic use (BAU) in NAPOLI-1 : A phase III study of liposomal irinotecan (nal IRI)+/- 5-fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) p
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 4, S. 379
  • Siveke, Jens; Hubner, R.; Macarulla, T. M.; Wang-Gillam, A.; Dean, A. P.; Blanc, J. F.; Cunningham, D.; Mirakhur, B.; Belanger, B.; de Jong, F. A.; Chen, L. T.
    Subgroup analysis by measurable metastatic lesion (ML) number and selected lesion locations (LL) at baseline (BL) in NAPOLI-1 : A phase III study of liposomal irinotecan (nal-IRI)+/- 5-fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pan
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 4, S. 460
  • Chen, Li Tzon; Macarulla, Teresa M.; Belanger, Bruce; Mirakhur, Beloo; Jong, Floris A. de; Siveke, Jens
    The prognostic value of the modified glasgow prognostic score (mGPS) in predicting overall survival (OS) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) receiving liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV)
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii255 - viii256
  • Heid, I.; Steiger, K.; Trajkovic-Arsic, M.; Settles, M.; Eißwein, M.; Erkan, M.; Kleeff, J.; Jäger, C.; Friess, H.; Haller, B.; Steingötter, A.; Schmid, R.; Schwaiger, M.; Rummeny, E.; Esposito, I.; Siveke, Jens; Braren, R.;
    Co-clinical assessment of tumor cellularity in pancreatic cancer
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 175
  • Siveke, Jens; Cubillo, A.; Blanc, J. F.; Melisi, D.; Von Hoff, D. D.; Wang-Gillam, A.; Chen, L. T.; Becker, C.; Mamlouk, K.; Belanger, B.; Yang, Y.; de Jong, F.; Hubner, R.
    Effects of nanoliposomal irinotecan (nal-IRI;MM-398) +/- 5-Fluorouracil and leucavorin (5-FU/LV) on quality of life (QoL) in NAPOLI-1 : a phase 3 study in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-b
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 259
  • Siveke, Jens; Chen, L. T.; Von Hoff, D. D.; Li, C.-P.; Wang-Gillam, A.; Bodoky, G.; Dean, A.; Shan, Y. S.; Jameson, G.; Macarulla, T.; Lee, K. H.; Cunningham, D.; Blanc, J. F.; Hubner, R. A.; Chiu, C. F.; Schwartsmann, G.; Braiteh, F.; Moyo, V.; Belanger, B.; Bayever, E.;
    Expanded analyses of NAPOLI-1 : Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based the
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; Berlin, 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 170
  • Kamyabi-Moghaddam, Z.; Wirth, M.; Babucke, M.; Blume, K.; Saur, D.; Schorn, S.; Martignoni, M. E.; Ceyhan, G.; Schmid, R. M.; Siveke, Jens; Schneider, G.; Reichert, M.;
    Patient-derived organoids to model intra- and intertumoral heterogeneity of pancreatic cancer in high-throughput drug screens
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 162
  • Pelzer, U.; Blanc, J. F.; Melisi, D.; Cubillo, A.; Von Hoff, D. D.; Wang-Gillam, A.; Chen, L. T.; Siveke, Jens; Wan, Y.; Solem, C. T.; Botteman, M.; Yang, Y.; de Jong, F.; Hubner, R.
    Quality-adjusted time without symptoms or toxicity (Q-TWIST) of nanoliposomal irinotecan (nal-IRI;MM-398) plus 5-fluorouracil and leucavorin (5-FU/LV) vs 5-FU/LV alone in patients with metastatic pancreatic adenocarcinoma (mPAC) previously treated with ge
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 260
  • Neff, F.; Kirsch, D. G.; Saur, D.; Schmid, R. M.; Bazhin, A.; Heikenwälder, M. F.; Siveke, Jens;
    Targeting notch for myeloid reprogramming in pancreatic cancer
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 16
  • Trajkovic-Arsic, M.; Heid, I.; Steiger, K.; Gupta, A.; Fingerle, A.; Wörner, C.; Teichmann, N.; Wenzel, P.; Herner, A.; Steingötter, A.; Beer, A.; Schweiger, M.; Settles, M.; Haller, B.; Esposito, I.; Rummeny, E.; Schmid, R. M.; Braren, R.; Siveke, Jens;
    Use of Diffusion-weighted magnetic resonance imaging for therapy response evaluation in pancreatic cancer
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 113 - 114
  • Moehler, M.; Thuss-Patience, P.; Schmoll, H. J.; Hegewisch-Becker, S.; Wilke, Hansjochen; Al-Batran, S. E.; Weissinger, F.; Kullmann, F.; von Weikerstahl, L. F.; Siveke, Jens; Kanzler, S.; Schimanski, C. C.; Otte, M.; Schollenberger, L.; Koenig, J.; Galle, P. R.;
    Na-Folfiri plus sunitinib versus Na-Folfiri alone in advanced chemorefractory esophagogastric cancer patients : A randomized double-blinded placebo-controlled multicentric AIO phase II trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 74
  • Bitzer, Michael; Horger, Markus; Ganten, Tom; Ebert, Matthias P.; Siveke, Jens; Woerns, Marcus A.; Dollinger, Matthias M.; Gerken, Guido; Scheulen, Max Ernst; Mais, Anna; Jankowsky, Rüdiger; Hauns, Bernhard; Hentsch, Bernd; Lauer, Ulrich M.;
    Clinical update on the phase I/II trial of HDAC inhibitor resminostat in patients with sorafenib-resistant hepatocellular carcinoma (HCC) - The Shelter Study
    13th World Congress on Gastrointestinal Cancer 22–25 June 2011, Barcelona, Spain,
    In: Annals of Oncology Jg. 22 (2011) Nr. Suppl. 5, S. v76 - v76